Abele john e - direct investment history in Boston scientific corp

Filed on 2012-08-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-018718.txt Sec File: edgar/data/901430/0001225208-12-018718-index.htm

2012-08-27 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 480272 shares at $0.0000 remaining shares owned 92983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on august 27, 2012, the reporting person settled a prepaid variable contract originally entered into on august 26, 2010 through the delivery of 480,272 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,773,353.54 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 486,090 shares. if the market price per share at maturity was equal to or less than the floor price of $5.3650 per share, the reporting person would deliver 486,090 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver proportionally fewer shares. the market price per share at maturity on august 27, 2012 was $5.43, exceeding the floor price. accordingly, the reporting person transferred 480,272 shares of the issuer's common stock to the bank.


Filed on 2012-08-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-018718.txt Sec File: edgar/data/901430/0001225208-12-018718-index.htm

2012-08-27 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 486090.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-08-27 item expiration due date 2012-08-27 underlying security shares 486090.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on august 27, 2012, the reporting person settled a prepaid variable contract originally entered into on august 26, 2010 through the delivery of 480,272 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,773,353.54 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 486,090 shares. if the market price per share at maturity was equal to or less than the floor price of $5.3650 per share, the reporting person would deliver 486,090 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver proportionally fewer shares. the market price per share at maturity on august 27, 2012 was $5.43, exceeding the floor price. accordingly, the reporting person transferred 480,272 shares of the issuer's common stock to the bank.


Filed on 2012-08-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-018718.txt Sec File: edgar/data/901430/0001225208-12-018718-index.htm

2012-08-27 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-08-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-018718.txt Sec File: edgar/data/901430/0001225208-12-018718-index.htm

2012-08-27 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-08-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-018348.txt Sec File: edgar/data/901430/0001225208-12-018348-index.htm

2012-08-17 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 480551 shares at $0.0000 remaining shares owned 573255

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on august 17, 2012, the reporting person settled a prepaid variable contract originally entered into on august 17, 2010 through the delivery of 480,551 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,813,237.65 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.4822 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver proportionally fewer shares. the market price per share at maturity on august 17, 2012 was $5.59, exceeding the floor price. accordingly, the reporting person transferred 480,551 shares of the issuer's common stock to the bank.


Filed on 2012-08-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-018348.txt Sec File: edgar/data/901430/0001225208-12-018348-index.htm

2012-08-17 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-08-17 item expiration due date 2012-08-17 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on august 17, 2012, the reporting person settled a prepaid variable contract originally entered into on august 17, 2010 through the delivery of 480,551 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,813,237.65 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.4822 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver proportionally fewer shares. the market price per share at maturity on august 17, 2012 was $5.59, exceeding the floor price. accordingly, the reporting person transferred 480,551 shares of the issuer's common stock to the bank.


Filed on 2012-08-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-018348.txt Sec File: edgar/data/901430/0001225208-12-018348-index.htm

2012-08-17 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-08-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-018348.txt Sec File: edgar/data/901430/0001225208-12-018348-index.htm

2012-08-17 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-08-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017896.txt Sec File: edgar/data/901430/0001225208-12-017896-index.htm

2012-08-13 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 488177 shares at $0.0000 remaining shares owned 1053806

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on august 13, 2012, the reporting person settled a prepaid variable contract originally entered into on august 13, 2010 through the delivery of 488,177 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,803,547.78 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.4895 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver proportionally fewer shares. the market price per share at maturity on august 13, 2012 was $5.51, exceeding the floor price. accordingly, the reporting person transferred 488,177 shares of the issuer's common stock to the bank.


Filed on 2012-08-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017896.txt Sec File: edgar/data/901430/0001225208-12-017896-index.htm

2012-08-13 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-08-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017896.txt Sec File: edgar/data/901430/0001225208-12-017896-index.htm

2012-08-13 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-08-13 item expiration due date 2012-08-13 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on august 13, 2012, the reporting person settled a prepaid variable contract originally entered into on august 13, 2010 through the delivery of 488,177 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,803,547.78 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.4895 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver proportionally fewer shares. the market price per share at maturity on august 13, 2012 was $5.51, exceeding the floor price. accordingly, the reporting person transferred 488,177 shares of the issuer's common stock to the bank.


Filed on 2012-08-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017896.txt Sec File: edgar/data/901430/0001225208-12-017896-index.htm

2012-08-13 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-08-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017485.txt Sec File: edgar/data/901430/0001225208-12-017485-index.htm

2012-08-06 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-08-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017485.txt Sec File: edgar/data/901430/0001225208-12-017485-index.htm

2012-08-06 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 1541983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on august 6, 2012, the reporting person settled a prepaid variable contract originally entered into on august 6, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,910,723.57 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.7051 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on august 6, 2012 was $5.26. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-08-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017485.txt Sec File: edgar/data/901430/0001225208-12-017485-index.htm

2012-08-06 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-08-06 item expiration due date 2012-08-06 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on august 6, 2012, the reporting person settled a prepaid variable contract originally entered into on august 6, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,910,723.57 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.7051 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on august 6, 2012 was $5.26. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-08-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017485.txt Sec File: edgar/data/901430/0001225208-12-017485-index.htm

2012-08-06 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-08-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017104.txt Sec File: edgar/data/901430/0001225208-12-017104-index.htm

2012-07-30 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-08-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017104.txt Sec File: edgar/data/901430/0001225208-12-017104-index.htm

2012-07-30 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-07-30 item expiration due date 2012-07-30 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on july 30, 2012, the reporting person settled a prepaid variable contract originally entered into on july 29, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,879,556.93 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.6063 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on july 30, 2012 was $5.16. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-08-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017104.txt Sec File: edgar/data/901430/0001225208-12-017104-index.htm

2012-07-30 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 2031983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on july 30, 2012, the reporting person settled a prepaid variable contract originally entered into on july 29, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,879,556.93 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.6063 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on july 30, 2012 was $5.16. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-08-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-017104.txt Sec File: edgar/data/901430/0001225208-12-017104-index.htm

2012-07-30 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-07-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016633.txt Sec File: edgar/data/901430/0001225208-12-016633-index.htm

2012-07-23 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 2521983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on july 23, 2012, the reporting person settled a prepaid variable contract originally entered into on july 23, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,011,790.06 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.9288 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on july 23, 2012 was $5.26. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-07-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016633.txt Sec File: edgar/data/901430/0001225208-12-016633-index.htm

2012-07-23 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-07-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016633.txt Sec File: edgar/data/901430/0001225208-12-016633-index.htm

2012-07-23 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-07-23 item expiration due date 2012-07-23 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on july 23, 2012, the reporting person settled a prepaid variable contract originally entered into on july 23, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,011,790.06 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.9288 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on july 23, 2012 was $5.26. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-07-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016633.txt Sec File: edgar/data/901430/0001225208-12-016633-index.htm

2012-07-23 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-07-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016455.txt Sec File: edgar/data/901430/0001225208-12-016455-index.htm

2012-07-16 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-07-16 item expiration due date 2012-07-16 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on july 16, 2012, the reporting person settled a prepaid variable contract originally entered into on july 16, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,147,723.04 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.2393 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on july 16, 2012 was $5.57. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-07-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016455.txt Sec File: edgar/data/901430/0001225208-12-016455-index.htm

2012-07-16 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 3011983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on july 16, 2012, the reporting person settled a prepaid variable contract originally entered into on july 16, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,147,723.04 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.2393 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on july 16, 2012 was $5.57. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-07-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016455.txt Sec File: edgar/data/901430/0001225208-12-016455-index.htm

2012-07-16 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-07-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016455.txt Sec File: edgar/data/901430/0001225208-12-016455-index.htm

2012-07-16 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-07-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016131.txt Sec File: edgar/data/901430/0001225208-12-016131-index.htm

2012-07-06 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-07-06 item expiration due date 2012-07-06 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on july 6, 2012, the reporting person settled a prepaid variable contract originally entered into on july 6, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,091,708.57 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.1070 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on july 6, 2012 was $5.65. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-07-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016131.txt Sec File: edgar/data/901430/0001225208-12-016131-index.htm

2012-07-06 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-07-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016131.txt Sec File: edgar/data/901430/0001225208-12-016131-index.htm

2012-07-06 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-07-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-016131.txt Sec File: edgar/data/901430/0001225208-12-016131-index.htm

2012-07-06 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 3501983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on july 6, 2012, the reporting person settled a prepaid variable contract originally entered into on july 6, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,091,708.57 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.1070 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on july 6, 2012 was $5.65. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-07-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-015260.txt Sec File: edgar/data/901430/0001225208-12-015260-index.htm

2012-06-28 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-28 item expiration due date 2012-06-28 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 28, 2012, the reporting person settled a prepaid variable contract originally entered into on june 28, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,080,246.78 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.0304 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on june 28, 2012 was $5.55. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-07-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-015260.txt Sec File: edgar/data/901430/0001225208-12-015260-index.htm

2012-06-28 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 3991983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 28, 2012, the reporting person settled a prepaid variable contract originally entered into on june 28, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,080,246.78 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.0304 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on june 28, 2012 was $5.55. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-07-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-015260.txt Sec File: edgar/data/901430/0001225208-12-015260-index.htm

2012-06-28 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-07-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-015260.txt Sec File: edgar/data/901430/0001225208-12-015260-index.htm

2012-06-28 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-06-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014976.txt Sec File: edgar/data/901430/0001225208-12-014976-index.htm

2012-06-25 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-06-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014976.txt Sec File: edgar/data/901430/0001225208-12-014976-index.htm

2012-06-25 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-06-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014976.txt Sec File: edgar/data/901430/0001225208-12-014976-index.htm

2012-06-25 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 4481983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 25, 2012, the reporting person settled a prepaid variable contract originally entered into on june 24, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,058,672.97 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.9934 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on june 25, 2012 was $5.52. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-06-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014976.txt Sec File: edgar/data/901430/0001225208-12-014976-index.htm

2012-06-25 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-25 item expiration due date 2012-06-25 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 25, 2012, the reporting person settled a prepaid variable contract originally entered into on june 24, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,058,672.97 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.9934 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on june 25, 2012 was $5.52. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-06-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014740.txt Sec File: edgar/data/901430/0001225208-12-014740-index.htm

2012-06-18 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-06-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014740.txt Sec File: edgar/data/901430/0001225208-12-014740-index.htm

2012-06-18 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-06-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014740.txt Sec File: edgar/data/901430/0001225208-12-014740-index.htm

2012-06-18 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-18 item expiration due date 2012-06-18 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 18, 2012, the reporting person settled a prepaid variable contract originally entered into on june 16, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,048,345.04 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.0584 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on june 18, 2012 was $5.78. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-06-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014740.txt Sec File: edgar/data/901430/0001225208-12-014740-index.htm

2012-06-18 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 4971983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 18, 2012, the reporting person settled a prepaid variable contract originally entered into on june 16, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,048,345.04 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.0584 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on june 18, 2012 was $5.78. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-06-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014226.txt Sec File: edgar/data/901430/0001225208-12-014226-index.htm

2012-06-08 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-06-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014226.txt Sec File: edgar/data/901430/0001225208-12-014226-index.htm

2012-06-08 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-06-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014226.txt Sec File: edgar/data/901430/0001225208-12-014226-index.htm

2012-06-08 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 470735.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-08 item expiration due date 2012-06-08 underlying security shares 470735.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 8, 2012, the reporting person settled a prepaid variable contract originally entered into on june 8, 2010 through the delivery of 470,735 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,804,921.49 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.4855 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver proportionally fewer shares. the market price per share at maturity on june 8, 2012 was $5.71, exceeding the floor price. accordingly, the reporting person transferred 470,735 shares of the issuer's common stock to the bank.


Filed on 2012-06-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-014226.txt Sec File: edgar/data/901430/0001225208-12-014226-index.htm

2012-06-08 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 470735 shares at $0.0000 remaining shares owned 5461983

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 8, 2012, the reporting person settled a prepaid variable contract originally entered into on june 8, 2010 through the delivery of 470,735 shares of the issuer's common stock. at the initiation of the contract, the bank paid $1,804,921.49 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $5.4855 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver proportionally fewer shares. the market price per share at maturity on june 8, 2012 was $5.71, exceeding the floor price. accordingly, the reporting person transferred 470,735 shares of the issuer's common stock to the bank.


Filed on 2012-06-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-013954.txt Sec File: edgar/data/901430/0001225208-12-013954-index.htm

2012-06-04 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-06-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-013954.txt Sec File: edgar/data/901430/0001225208-12-013954-index.htm

2012-06-04 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-06-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-013954.txt Sec File: edgar/data/901430/0001225208-12-013954-index.htm

2012-06-04 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-04 item expiration due date 2012-06-04 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 4, 2012, the reporting person settled a prepaid variable contract originally entered into on june 2, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,005,504.34 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.0680 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on june 4, 2012 was $5.59. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-06-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-013954.txt Sec File: edgar/data/901430/0001225208-12-013954-index.htm

2012-06-04 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 5932718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on june 4, 2012, the reporting person settled a prepaid variable contract originally entered into on june 2, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,005,504.34 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.0680 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on june 4, 2012 was $5.59. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-013456.txt Sec File: edgar/data/901430/0001225208-12-013456-index.htm

2012-05-29 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-05-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-013456.txt Sec File: edgar/data/901430/0001225208-12-013456-index.htm

2012-05-29 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-05-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-013456.txt Sec File: edgar/data/901430/0001225208-12-013456-index.htm

2012-05-29 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-05-29 item expiration due date 2012-05-29 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on may 29, 2012, the reporting person settled a prepaid variable contract originally entered into on may 26, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,001,480.95 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.0965 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on may 29, 2012 was $5.90. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-013456.txt Sec File: edgar/data/901430/0001225208-12-013456-index.htm

2012-05-29 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 6422718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on may 29, 2012, the reporting person settled a prepaid variable contract originally entered into on may 26, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,001,480.95 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.0965 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on may 29, 2012 was $5.90. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-012987.txt Sec File: edgar/data/901430/0001225208-12-012987-index.htm

2012-05-18 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-05-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-012987.txt Sec File: edgar/data/901430/0001225208-12-012987-index.htm

2012-05-18 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-05-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-012987.txt Sec File: edgar/data/901430/0001225208-12-012987-index.htm

2012-05-18 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-05-18 item expiration due date 2012-05-18 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on may 18, 2012, the reporting person settled a prepaid variable contract originally entered into on may 18, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,298,168.60 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.7002 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on may 18, 2012 was $5.96. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-012987.txt Sec File: edgar/data/901430/0001225208-12-012987-index.htm

2012-05-18 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 6912718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on may 18, 2012, the reporting person settled a prepaid variable contract originally entered into on may 18, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,298,168.60 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.7002 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on may 18, 2012 was $5.96. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-012459.txt Sec File: edgar/data/901430/0001225208-12-012459-index.htm

2012-05-11 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-05-11 item expiration due date 2012-05-11 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on may 11, 2012, the reporting person settled a prepaid variable contract originally entered into on may 11, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,234,620.99 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.5618 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on may 11, 2012 was $6.31. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-012459.txt Sec File: edgar/data/901430/0001225208-12-012459-index.htm

2012-05-11 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 7402718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on may 11, 2012, the reporting person settled a prepaid variable contract originally entered into on may 11, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,234,620.99 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.5618 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on may 11, 2012 was $6.31. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-012459.txt Sec File: edgar/data/901430/0001225208-12-012459-index.htm

2012-05-11 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-05-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-012459.txt Sec File: edgar/data/901430/0001225208-12-012459-index.htm

2012-05-11 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-05-09 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-011774.txt Sec File: edgar/data/901430/0001225208-12-011774-index.htm

2012-05-07 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 7892718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on may 7, 2012, the reporting person settled a prepaid variable contract originally entered into on may 6, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,253,631.52 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.7636 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on may 7, 2012 was $6.31. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-09 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-011774.txt Sec File: edgar/data/901430/0001225208-12-011774-index.htm

2012-05-07 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-05-07 item expiration due date 2012-05-07 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on may 7, 2012, the reporting person settled a prepaid variable contract originally entered into on may 6, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,253,631.52 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.7636 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on may 7, 2012 was $6.31. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-09 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-011774.txt Sec File: edgar/data/901430/0001225208-12-011774-index.htm

2012-05-07 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-05-09 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-011774.txt Sec File: edgar/data/901430/0001225208-12-011774-index.htm

2012-05-07 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-05-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-010928.txt Sec File: edgar/data/901430/0001225208-12-010928-index.htm

2012-04-30 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-04-30 item expiration due date 2012-04-30 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 30, 2012, the reporting person settled a prepaid variable contract originally entered into on april 29, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,430,020.25 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.9750 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 30, 2012 was $6.26. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-010928.txt Sec File: edgar/data/901430/0001225208-12-010928-index.htm

2012-04-30 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 8382718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 30, 2012, the reporting person settled a prepaid variable contract originally entered into on april 29, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,430,020.25 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.9750 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 30, 2012 was $6.26. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-05-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-010928.txt Sec File: edgar/data/901430/0001225208-12-010928-index.htm

2012-04-30 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-05-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-010928.txt Sec File: edgar/data/901430/0001225208-12-010928-index.htm

2012-04-30 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-010101.txt Sec File: edgar/data/901430/0001225208-12-010101-index.htm

2012-04-19 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-010101.txt Sec File: edgar/data/901430/0001225208-12-010101-index.htm

2012-04-19 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-010101.txt Sec File: edgar/data/901430/0001225208-12-010101-index.htm

2012-04-19 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 8872718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 19, 2012, the reporting person settled a prepaid variable contract originally entered into on april 19, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,566,477.54 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $7.3347 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 19, 2012 was $5.85. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-010101.txt Sec File: edgar/data/901430/0001225208-12-010101-index.htm

2012-04-19 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-04-19 item expiration due date 2012-04-19 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 19, 2012, the reporting person settled a prepaid variable contract originally entered into on april 19, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,566,477.54 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $7.3347 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 19, 2012 was $5.85. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-04-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009840.txt Sec File: edgar/data/901430/0001225208-12-009840-index.htm

2012-04-12 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-04-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009840.txt Sec File: edgar/data/901430/0001225208-12-009840-index.htm

2012-04-12 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-04-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009840.txt Sec File: edgar/data/901430/0001225208-12-009840-index.htm

2012-04-12 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-04-12 item expiration due date 2012-04-12 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 12, 2012, the reporting person settled a prepaid variable contract originally entered into on april 12, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,452,383.37 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $7.0382 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 12, 2012 was $5.82. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-04-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009840.txt Sec File: edgar/data/901430/0001225208-12-009840-index.htm

2012-04-12 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 9362718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 12, 2012, the reporting person settled a prepaid variable contract originally entered into on april 12, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,452,383.37 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $7.0382 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 12, 2012 was $5.82. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-04-11 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009657.txt Sec File: edgar/data/901430/0001225208-12-009657-index.htm

2012-04-09 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-04-11 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009657.txt Sec File: edgar/data/901430/0001225208-12-009657-index.htm

2012-04-09 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-04-11 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009657.txt Sec File: edgar/data/901430/0001225208-12-009657-index.htm

2012-04-09 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-04-09 item expiration due date 2012-04-09 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 9, 2012, the reporting person settled a prepaid variable contract originally entered into on april 8, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,454,128.84 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $7.0442 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 9, 2012 was $5.84. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-04-11 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009657.txt Sec File: edgar/data/901430/0001225208-12-009657-index.htm

2012-04-09 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 9852718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 9, 2012, the reporting person settled a prepaid variable contract originally entered into on april 8, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,454,128.84 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $7.0442 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 9, 2012 was $5.84. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-04-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009439.txt Sec File: edgar/data/901430/0001225208-12-009439-index.htm

2012-04-02 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-04-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009439.txt Sec File: edgar/data/901430/0001225208-12-009439-index.htm

2012-04-02 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-04-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009439.txt Sec File: edgar/data/901430/0001225208-12-009439-index.htm

2012-04-02 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-04-02 item expiration due date 2012-04-02 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 2, 2012, the reporting person settled a prepaid variable contract originally entered into on march 31, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,509,696.36 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $7.2230 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 2, 2012 was $5.97. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-04-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-009439.txt Sec File: edgar/data/901430/0001225208-12-009439-index.htm

2012-04-02 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 10342718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on april 2, 2012, the reporting person settled a prepaid variable contract originally entered into on march 31, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,509,696.36 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $7.2230 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on april 2, 2012 was $5.97. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-03-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-008371.txt Sec File: edgar/data/901430/0001225208-12-008371-index.htm

2012-03-23 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-03-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-008371.txt Sec File: edgar/data/901430/0001225208-12-008371-index.htm

2012-03-23 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-03-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-008371.txt Sec File: edgar/data/901430/0001225208-12-008371-index.htm

2012-03-23 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-03-23 item expiration due date 2012-03-23 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on march 23, 2012, the reporting person settled a prepaid variable contract originally entered into on march 23, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,425,477.17 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.8654 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on march 23, 2012 was $5.97. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-03-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-008371.txt Sec File: edgar/data/901430/0001225208-12-008371-index.htm

2012-03-23 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 10832718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on march 23, 2012, the reporting person settled a prepaid variable contract originally entered into on march 23, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,425,477.17 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.8654 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on march 23, 2012 was $5.97. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-03-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-007975.txt Sec File: edgar/data/901430/0001225208-12-007975-index.htm

2012-03-15 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-03-15 item expiration due date 2012-03-15 underlying security shares 490000.0000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on march 15, 2012, the reporting person settled a prepaid variable contract originally entered into on march 15, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,364,412.97 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.6972 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on march 15, 2012 was $6.00. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-03-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-007975.txt Sec File: edgar/data/901430/0001225208-12-007975-index.htm

2012-03-15 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp sold 490000 shares at $0.0000 remaining shares owned 11322718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 1, 2010, the reporting person entered into a trading plan intended to comply with the requirements of rule 10b5-1 with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on march 15, 2012, the reporting person settled a prepaid variable contract originally entered into on march 15, 2010 through the delivery of 490,000 shares of the issuer's common stock. at the initiation of the contract, the bank paid $2,364,412.97 to the reporting person. see also footnote 2.
f2 in accordance with the variable prepaid forward sale contract, when settled in shares the number of shares to be delivered to the bank at maturity depends on the market price per share at maturity, but may not exceed 490,000 shares. if the market price per share at maturity was equal to or less than the floor price of $6.6972 per share, the reporting person would deliver 490,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share at maturity on march 15, 2012 was $6.00. accordingly, the reporting person transferred 490,000 shares of the issuer's common stock to the bank.


Filed on 2012-03-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-007975.txt Sec File: edgar/data/901430/0001225208-12-007975-index.htm

2012-03-15 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2012-03-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-12-007975.txt Sec File: edgar/data/901430/0001225208-12-007975-index.htm

2012-03-15 Abele John E (CIK 901430) through Direct (Director Emeritus)

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023646.txt Sec File: edgar/data/901430/0001225208-10-023646-index.htm

2010-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023646.txt Sec File: edgar/data/901430/0001225208-10-023646-index.htm

2010-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-27 item expiration due date 2010-10-27 underlying security shares 50000.0000 underlying security title Common Stock

f1 on october 27, 2010, the reporting person settled a prepaid variable contract originally entered into on october 27, 2009. at the initiation of the contract, the bank paid $357,820.25 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.4193 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares but not less than 35,700 shares. the closing market price per share on october 27, 2010 was $6.31. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023646.txt Sec File: edgar/data/901430/0001225208-10-023646-index.htm

2010-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 11762718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on october 27, 2010, the reporting person settled a prepaid variable contract originally entered into on october 27, 2009. at the initiation of the contract, the bank paid $357,820.25 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.4193 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares but not less than 35,700 shares. the closing market price per share on october 27, 2010 was $6.31. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023646.txt Sec File: edgar/data/901430/0001225208-10-023646-index.htm

2010-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023646.txt Sec File: edgar/data/901430/0001225208-10-023646-index.htm

2010-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023524.txt Sec File: edgar/data/901430/0001225208-10-023524-index.htm

2010-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-26 item expiration due date 2010-10-26 underlying security shares 50000.0000 underlying security title Common Stock

f1 on october 26, 2010, the reporting person settled a prepaid variable contract originally entered into on october 26, 2009. at the initiation of the contract, the bank paid $363,428.84 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.5162 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 26, 2010 was $6.29. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023524.txt Sec File: edgar/data/901430/0001225208-10-023524-index.htm

2010-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023524.txt Sec File: edgar/data/901430/0001225208-10-023524-index.htm

2010-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023524.txt Sec File: edgar/data/901430/0001225208-10-023524-index.htm

2010-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023524.txt Sec File: edgar/data/901430/0001225208-10-023524-index.htm

2010-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 11812718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on october 26, 2010, the reporting person settled a prepaid variable contract originally entered into on october 26, 2009. at the initiation of the contract, the bank paid $363,428.84 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.5162 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 26, 2010 was $6.29. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023441.txt Sec File: edgar/data/901430/0001225208-10-023441-index.htm

2010-10-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023441.txt Sec File: edgar/data/901430/0001225208-10-023441-index.htm

2010-10-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-22 item expiration due date 2010-10-22 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 22, 2010, the reporting person settled a prepaid variable contract originally entered into on october 23, 2009. at the initiation of the contract, the bank paid $346,604.35 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.6435 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 22, 2010 was $6.30. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023441.txt Sec File: edgar/data/901430/0001225208-10-023441-index.htm

2010-10-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 11862718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 22, 2010, the reporting person settled a prepaid variable contract originally entered into on october 23, 2009. at the initiation of the contract, the bank paid $346,604.35 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.6435 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 22, 2010 was $6.30. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023441.txt Sec File: edgar/data/901430/0001225208-10-023441-index.htm

2010-10-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023441.txt Sec File: edgar/data/901430/0001225208-10-023441-index.htm

2010-10-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023389.txt Sec File: edgar/data/901430/0001225208-10-023389-index.htm

2010-10-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023389.txt Sec File: edgar/data/901430/0001225208-10-023389-index.htm

2010-10-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-21 item expiration due date 2010-10-21 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 21, 2010, the reporting person settled a prepaid variable contract originally entered into on october 21, 2009. at the initiation of the contract, the bank paid $332,588.00 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.3147 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 21, 2010 was $6.34. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023389.txt Sec File: edgar/data/901430/0001225208-10-023389-index.htm

2010-10-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 11912718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 21, 2010, the reporting person settled a prepaid variable contract originally entered into on october 21, 2009. at the initiation of the contract, the bank paid $332,588.00 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.3147 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 21, 2010 was $6.34. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023389.txt Sec File: edgar/data/901430/0001225208-10-023389-index.htm

2010-10-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023389.txt Sec File: edgar/data/901430/0001225208-10-023389-index.htm

2010-10-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023366.txt Sec File: edgar/data/901430/0001225208-10-023366-index.htm

2010-10-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023366.txt Sec File: edgar/data/901430/0001225208-10-023366-index.htm

2010-10-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-20 item expiration due date 2010-10-20 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 20, 2010, the reporting person settled a prepaid variable contract originally entered into on october 20, 2009. at the initiation of the contract, the bank paid $338,127.46 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.4978 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 20, 2010 was $6.30. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023366.txt Sec File: edgar/data/901430/0001225208-10-023366-index.htm

2010-10-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 11962718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 20, 2010, the reporting person settled a prepaid variable contract originally entered into on october 20, 2009. at the initiation of the contract, the bank paid $338,127.46 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.4978 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 20, 2010 was $6.30. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023366.txt Sec File: edgar/data/901430/0001225208-10-023366-index.htm

2010-10-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023366.txt Sec File: edgar/data/901430/0001225208-10-023366-index.htm

2010-10-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023318.txt Sec File: edgar/data/901430/0001225208-10-023318-index.htm

2010-10-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-19 item expiration due date 2010-10-19 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 19, 2010, the reporting person settled a prepaid variable contract originally entered into on october 19, 2009. at the initiation of the contract, the bank paid $412,132.18 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.2228 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 19, 2010 was $5.97. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023318.txt Sec File: edgar/data/901430/0001225208-10-023318-index.htm

2010-10-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023318.txt Sec File: edgar/data/901430/0001225208-10-023318-index.htm

2010-10-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023318.txt Sec File: edgar/data/901430/0001225208-10-023318-index.htm

2010-10-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023318.txt Sec File: edgar/data/901430/0001225208-10-023318-index.htm

2010-10-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12012718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 19, 2010, the reporting person settled a prepaid variable contract originally entered into on october 19, 2009. at the initiation of the contract, the bank paid $412,132.18 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.2228 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 19, 2010 was $5.97. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023269.txt Sec File: edgar/data/901430/0001225208-10-023269-index.htm

2010-10-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023269.txt Sec File: edgar/data/901430/0001225208-10-023269-index.htm

2010-10-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-18 item expiration due date 2010-10-18 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 18, 2010, the reporting person settled a prepaid variable contract originally entered into on october 16, 2009. at the initiation of the contract, the bank paid $401,711.10 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $9.9804 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than $9.9804, the reporting person would deliver a fewer number of shares. the closing market price per share on october 18, 2010 was $6.20. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023269.txt Sec File: edgar/data/901430/0001225208-10-023269-index.htm

2010-10-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12062718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 18, 2010, the reporting person settled a prepaid variable contract originally entered into on october 16, 2009. at the initiation of the contract, the bank paid $401,711.10 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $9.9804 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than $9.9804, the reporting person would deliver a fewer number of shares. the closing market price per share on october 18, 2010 was $6.20. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023269.txt Sec File: edgar/data/901430/0001225208-10-023269-index.htm

2010-10-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023269.txt Sec File: edgar/data/901430/0001225208-10-023269-index.htm

2010-10-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023217.txt Sec File: edgar/data/901430/0001225208-10-023217-index.htm

2010-10-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023217.txt Sec File: edgar/data/901430/0001225208-10-023217-index.htm

2010-10-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-15 item expiration due date 2010-10-15 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 15, 2010, the reporting person settled a prepaid variable contract originally entered into on october 15, 2009. at the initiation of the contract, the bank paid $405,894.39 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.0906 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than $10.0906, the reporting person would deliver a fewer number of shares. the closing market price per share on october 15, 2010 was $6.15. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023217.txt Sec File: edgar/data/901430/0001225208-10-023217-index.htm

2010-10-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12112718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 15, 2010, the reporting person settled a prepaid variable contract originally entered into on october 15, 2009. at the initiation of the contract, the bank paid $405,894.39 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.0906 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than $10.0906, the reporting person would deliver a fewer number of shares. the closing market price per share on october 15, 2010 was $6.15. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023217.txt Sec File: edgar/data/901430/0001225208-10-023217-index.htm

2010-10-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023217.txt Sec File: edgar/data/901430/0001225208-10-023217-index.htm

2010-10-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023154.txt Sec File: edgar/data/901430/0001225208-10-023154-index.htm

2010-10-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023154.txt Sec File: edgar/data/901430/0001225208-10-023154-index.htm

2010-10-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-14 item expiration due date 2010-10-14 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 14, 2010, the reporting person settled a prepaid variable contract originally entered into on october 14, 2009. at the initiation of the contract, the bank paid $403,031.44 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.0294 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than $10.0294, the reporting person would deliver a fewer number of shares. the closing market price per share on october 14, 2010 was $6.16. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023154.txt Sec File: edgar/data/901430/0001225208-10-023154-index.htm

2010-10-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12162718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 14, 2010, the reporting person settled a prepaid variable contract originally entered into on october 14, 2009. at the initiation of the contract, the bank paid $403,031.44 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.0294 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than $10.0294, the reporting person would deliver a fewer number of shares. the closing market price per share on october 14, 2010 was $6.16. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023154.txt Sec File: edgar/data/901430/0001225208-10-023154-index.htm

2010-10-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023154.txt Sec File: edgar/data/901430/0001225208-10-023154-index.htm

2010-10-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023071.txt Sec File: edgar/data/901430/0001225208-10-023071-index.htm

2010-10-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-13 item expiration due date 2010-10-13 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 13, 2010, the reporting person settled a prepaid variable contract originally entered into on october 13, 2009. at the initiation of the contract, the bank paid $399,053.34 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $9.9403 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 13, 2010 was $6.21. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023071.txt Sec File: edgar/data/901430/0001225208-10-023071-index.htm

2010-10-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023071.txt Sec File: edgar/data/901430/0001225208-10-023071-index.htm

2010-10-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023071.txt Sec File: edgar/data/901430/0001225208-10-023071-index.htm

2010-10-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023071.txt Sec File: edgar/data/901430/0001225208-10-023071-index.htm

2010-10-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12212718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 13, 2010, the reporting person settled a prepaid variable contract originally entered into on october 13, 2009. at the initiation of the contract, the bank paid $399,053.34 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $9.9403 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 13, 2010 was $6.21. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023046.txt Sec File: edgar/data/901430/0001225208-10-023046-index.htm

2010-10-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-12 item expiration due date 2010-10-12 underlying security shares 50000.0000 underlying security title Common Stock

f3 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 12, 2010, the reporting person settled a prepaid variable contract originally entered into on october 12, 2009. at the initiation of the contract, the bank paid $403,911.42 to the reporting person.
f4 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.0538 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 12, 2010 was $6.13. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023046.txt Sec File: edgar/data/901430/0001225208-10-023046-index.htm

2010-10-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023046.txt Sec File: edgar/data/901430/0001225208-10-023046-index.htm

2010-10-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f6 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023046.txt Sec File: edgar/data/901430/0001225208-10-023046-index.htm

2010-10-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f7 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023046.txt Sec File: edgar/data/901430/0001225208-10-023046-index.htm

2010-10-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12312718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 12, 2010, the reporting person settled a prepaid variable contract originally entered into on october 9, 2009. at the initiation of the contract, the bank paid $413,673.90 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.2840 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 12, 2010 was $6.13. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023046.txt Sec File: edgar/data/901430/0001225208-10-023046-index.htm

2010-10-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12262718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f3 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 12, 2010, the reporting person settled a prepaid variable contract originally entered into on october 12, 2009. at the initiation of the contract, the bank paid $403,911.42 to the reporting person.
f4 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.0538 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 12, 2010 was $6.13. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-023046.txt Sec File: edgar/data/901430/0001225208-10-023046-index.htm

2010-10-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-12 item expiration due date 2010-10-12 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 12, 2010, the reporting person settled a prepaid variable contract originally entered into on october 9, 2009. at the initiation of the contract, the bank paid $413,673.90 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.2840 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 12, 2010 was $6.13. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022940.txt Sec File: edgar/data/901430/0001225208-10-022940-index.htm

2010-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12362718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 8, 2010, the reporting person settled a prepaid variable contract originally entered into on october 8, 2009. at the initiation of the contract, the bank paid $413,697.57 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.3038 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than $10.3038, the reporting person would deliver a fewer number of shares. the closing market price per share on october 8, 2010 was $6.15. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022940.txt Sec File: edgar/data/901430/0001225208-10-022940-index.htm

2010-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-08 item expiration due date 2010-10-08 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 8, 2010, the reporting person settled a prepaid variable contract originally entered into on october 8, 2009. at the initiation of the contract, the bank paid $413,697.57 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.3038 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than $10.3038, the reporting person would deliver a fewer number of shares. the closing market price per share on october 8, 2010 was $6.15. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022940.txt Sec File: edgar/data/901430/0001225208-10-022940-index.htm

2010-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022940.txt Sec File: edgar/data/901430/0001225208-10-022940-index.htm

2010-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022940.txt Sec File: edgar/data/901430/0001225208-10-022940-index.htm

2010-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022830.txt Sec File: edgar/data/901430/0001225208-10-022830-index.htm

2010-10-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022830.txt Sec File: edgar/data/901430/0001225208-10-022830-index.htm

2010-10-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022830.txt Sec File: edgar/data/901430/0001225208-10-022830-index.htm

2010-10-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022830.txt Sec File: edgar/data/901430/0001225208-10-022830-index.htm

2010-10-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-07 item expiration due date 2010-10-07 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 7, 2010, the reporting person settled a prepaid variable contract originally entered into on october 7, 2009. at the initiation of the contract, the bank paid $405,816.01 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.1201 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 7, 2010 was $6.16. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022830.txt Sec File: edgar/data/901430/0001225208-10-022830-index.htm

2010-10-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12412718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 7, 2010, the reporting person settled a prepaid variable contract originally entered into on october 7, 2009. at the initiation of the contract, the bank paid $405,816.01 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $10.1201 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 7, 2010 was $6.16. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022518.txt Sec File: edgar/data/901430/0001225208-10-022518-index.htm

2010-10-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022518.txt Sec File: edgar/data/901430/0001225208-10-022518-index.htm

2010-10-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022518.txt Sec File: edgar/data/901430/0001225208-10-022518-index.htm

2010-10-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-06 item expiration due date 2010-10-06 underlying security shares 50000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 6, 2010, the reporting person settled a prepaid variable contract originally entered into on october 6, 2009. at the initiation of the contract, the bank paid $397,136.69 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $9.9086 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 6, 2010 was $6.14. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022518.txt Sec File: edgar/data/901430/0001225208-10-022518-index.htm

2010-10-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0.0000 remaining shares owned 12462718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 6, 2010, the reporting person settled a prepaid variable contract originally entered into on october 6, 2009. at the initiation of the contract, the bank paid $397,136.69 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $9.9086 per share, the reporting person would deliver 50,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the closing market price per share on october 6, 2010 was $6.14. accordingly, the reporting person transferred to the bank 50,000 shares of the issuer's common stock.


Filed on 2010-10-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022518.txt Sec File: edgar/data/901430/0001225208-10-022518-index.htm

2010-10-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022335.txt Sec File: edgar/data/901430/0001225208-10-022335-index.htm

2010-10-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022335.txt Sec File: edgar/data/901430/0001225208-10-022335-index.htm

2010-10-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-10-03 item expiration due date 2011-10-03 underlying security shares 60000.0000 underlying security title Common Stock

f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on october 3, 2011. in addition, if the market price per share was equal to or greater than $12.0409 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $12.0409 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.0341 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.0341, the reporting person would deliver a fewer number of shares. the closing market price per share on october 4, 2010 was $6.08. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 4, 2010, the reporting person settled a prepaid variable contract originally entered into on october 2, 2009. at the initiation of the contract, the bank paid $482,539.87 to the reporting person.


Filed on 2010-10-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022335.txt Sec File: edgar/data/901430/0001225208-10-022335-index.htm

2010-10-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022335.txt Sec File: edgar/data/901430/0001225208-10-022335-index.htm

2010-10-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-022335.txt Sec File: edgar/data/901430/0001225208-10-022335-index.htm

2010-10-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0.0000 remaining shares owned 12512718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on october 4, 2010, the reporting person settled a prepaid variable contract originally entered into on october 2, 2009. at the initiation of the contract, the bank paid $482,539.87 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on october 3, 2011. in addition, if the market price per share was equal to or greater than $12.0409 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $12.0409 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.0341 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.0341, the reporting person would deliver a fewer number of shares. the closing market price per share on october 4, 2010 was $6.08. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.


Filed on 2010-10-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021714.txt Sec File: edgar/data/901430/0001225208-10-021714-index.htm

2010-09-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021714.txt Sec File: edgar/data/901430/0001225208-10-021714-index.htm

2010-09-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-10-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021714.txt Sec File: edgar/data/901430/0001225208-10-021714-index.htm

2010-09-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0.0000 remaining shares owned 12572718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 29, 2010, the reporting person settled a prepaid variable contract originally entered into on september 29, 2009. at the initiation of the contract, the bank paid $516,662.77 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 29, 2011. in addition, if the market price per share was equal to or greater than $12.8443 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $12.8443 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.7036 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.7036, the reporting person would deliver a fewer number of shares. the closing market price per share on september 29, 2010 was $6.11. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.


Filed on 2010-10-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021714.txt Sec File: edgar/data/901430/0001225208-10-021714-index.htm

2010-09-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-10-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021714.txt Sec File: edgar/data/901430/0001225208-10-021714-index.htm

2010-09-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-29 item expiration due date 2011-09-29 underlying security shares 60000.0000 underlying security title Common Stock

f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 29, 2011. in addition, if the market price per share was equal to or greater than $12.8443 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $12.8443 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.7036 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.7036, the reporting person would deliver a fewer number of shares. the closing market price per share on september 29, 2010 was $6.11. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 29, 2010, the reporting person settled a prepaid variable contract originally entered into on september 29, 2009. at the initiation of the contract, the bank paid $516,662.77 to the reporting person.


Filed on 2010-09-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021476.txt Sec File: edgar/data/901430/0001225208-10-021476-index.htm

2010-09-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021476.txt Sec File: edgar/data/901430/0001225208-10-021476-index.htm

2010-09-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-26 item expiration due date 2011-09-26 underlying security shares 60000.0000 underlying security title Common Stock

f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 26, 2011. in addition, if the market price per share was equal to or greater than $12.7780 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $12.7780 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.6483 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.6483, the reporting person would deliver a fewer number of shares. the closing market price per share on september 24, 2010 was $5.75. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 24, 2010, the reporting person settled a prepaid variable contract originally entered into on september 24, 2009. at the initiation of the contract, the bank paid $514,632.34 to the reporting person.


Filed on 2010-09-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021476.txt Sec File: edgar/data/901430/0001225208-10-021476-index.htm

2010-09-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0.0000 remaining shares owned 12632718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 24, 2010, the reporting person settled a prepaid variable contract originally entered into on september 24, 2009. at the initiation of the contract, the bank paid $514,632.34 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 26, 2011. in addition, if the market price per share was equal to or greater than $12.7780 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $12.7780 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.6483 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.6483, the reporting person would deliver a fewer number of shares. the closing market price per share on september 24, 2010 was $5.75. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.


Filed on 2010-09-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021476.txt Sec File: edgar/data/901430/0001225208-10-021476-index.htm

2010-09-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021476.txt Sec File: edgar/data/901430/0001225208-10-021476-index.htm

2010-09-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-09-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021407.txt Sec File: edgar/data/901430/0001225208-10-021407-index.htm

2010-09-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-09-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021407.txt Sec File: edgar/data/901430/0001225208-10-021407-index.htm

2010-09-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-22 item expiration due date 2011-09-22 underlying security shares 60000.0000 underlying security title Common Stock

f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 22, 2011. in addition, if the market price per share was equal to or greater than $13.1622 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.1622 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.9685 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.9685, the reporting person would deliver a fewer number of shares. the closing market price per share on september 22, 2010 was $5.62. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 22, 2010, the reporting person settled a prepaid variable contract originally entered into on september 22, 2009. at the initiation of the contract, the bank paid $530,765.72 to the reporting person.


Filed on 2010-09-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021407.txt Sec File: edgar/data/901430/0001225208-10-021407-index.htm

2010-09-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0.0000 remaining shares owned 12692718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 22, 2010, the reporting person settled a prepaid variable contract originally entered into on september 22, 2009. at the initiation of the contract, the bank paid $530,765.72 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 22, 2011. in addition, if the market price per share was equal to or greater than $13.1622 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.1622 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.9685 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.9685, the reporting person would deliver a fewer number of shares. the closing market price per share on september 22, 2010 was $5.62. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.


Filed on 2010-09-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021407.txt Sec File: edgar/data/901430/0001225208-10-021407-index.htm

2010-09-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021407.txt Sec File: edgar/data/901430/0001225208-10-021407-index.htm

2010-09-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021287.txt Sec File: edgar/data/901430/0001225208-10-021287-index.htm

2010-09-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021287.txt Sec File: edgar/data/901430/0001225208-10-021287-index.htm

2010-09-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-19 item expiration due date 2011-09-19 underlying security shares 60000.0000 underlying security title Common Stock

f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 19, 2011. in addition, if the market price per share was equal to or greater than $13.137 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.137 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.9482 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.9482, the reporting person would deliver a fewer number of shares. the closing market price per share on september 20, 2010 was $5.54. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 20, 2010, the reporting person settled a prepaid variable contract originally entered into on september 18, 2009. at the initiation of the contract, the bank paid $528,141.17 to the reporting person.


Filed on 2010-09-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021287.txt Sec File: edgar/data/901430/0001225208-10-021287-index.htm

2010-09-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0.0000 remaining shares owned 12752718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 20, 2010, the reporting person settled a prepaid variable contract originally entered into on september 18, 2009. at the initiation of the contract, the bank paid $528,141.17 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 19, 2011. in addition, if the market price per share was equal to or greater than $13.137 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.137 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $10.9482 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $10.9482, the reporting person would deliver a fewer number of shares. the closing market price per share on september 20, 2010 was $5.54. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.


Filed on 2010-09-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021287.txt Sec File: edgar/data/901430/0001225208-10-021287-index.htm

2010-09-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021287.txt Sec File: edgar/data/901430/0001225208-10-021287-index.htm

2010-09-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-09-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021179.txt Sec File: edgar/data/901430/0001225208-10-021179-index.htm

2010-09-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-09-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021179.txt Sec File: edgar/data/901430/0001225208-10-021179-index.htm

2010-09-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000.0000 shares at $0.0000 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx execution date 2010-09-17 exercise date 2011-09-19 item expiration due date 2011-09-19 underlying security shares 60000.0000 underlying security title Common Stock

f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 19, 2011. in addition, if the market price per share was equal to or greater than $13.236 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.236 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $11.03 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $11.03, the reporting person would deliver a fewer number of shares. the closing market price per share on september 17, 2010 was $5.42. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 17, 2010, the reporting person settled a prepaid variable contract originally entered into on september 17, 2009. at the initiation of the contract, the bank paid $532,087.20 to the reporting person.


Filed on 2010-09-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021179.txt Sec File: edgar/data/901430/0001225208-10-021179-index.htm

2010-09-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0 remaining shares owned 12812718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 17, 2010, the reporting person settled a prepaid variable contract originally entered into on september 17, 2009. at the initiation of the contract, the bank paid $532,087.20 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 19, 2011. in addition, if the market price per share was equal to or greater than $13.236 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.236 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $11.03 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $11.03, the reporting person would deliver a fewer number of shares. the closing market price per share on september 17, 2010 was $5.42. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.


Filed on 2010-09-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021179.txt Sec File: edgar/data/901430/0001225208-10-021179-index.htm

2010-09-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-021179.txt Sec File: edgar/data/901430/0001225208-10-021179-index.htm

2010-09-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020777.txt Sec File: edgar/data/901430/0001225208-10-020777-index.htm

2010-09-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0.0000 remaining shares owned 12872718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 10, 2010, the reporting person settled a prepaid variable contract originally entered into on september 10, 2009. at the initiation of the contract, the bank paid $559,665.54 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 12, 2011. in addition, if the market price per share was equal to or greater than $13.9341 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.9341 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $11.6118 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $11.6118 the reporting person would deliver a fewer number of shares. the closing market price per share on september 10, 2010 was $5.33. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer's common stock.


Filed on 2010-09-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020777.txt Sec File: edgar/data/901430/0001225208-10-020777-index.htm

2010-09-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-09-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020777.txt Sec File: edgar/data/901430/0001225208-10-020777-index.htm

2010-09-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020777.txt Sec File: edgar/data/901430/0001225208-10-020777-index.htm

2010-09-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020777.txt Sec File: edgar/data/901430/0001225208-10-020777-index.htm

2010-09-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-12 item expiration due date 2011-09-12 underlying security shares 60000.0000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 10, 2010, the reporting person settled a prepaid variable contract originally entered into on september 10, 2009. at the initiation of the contract, the bank paid $559,665.54 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 12, 2011. in addition, if the market price per share was equal to or greater than $13.9341 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.9341 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $11.6118 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $11.6118 the reporting person would deliver a fewer number of shares. the closing market price per share on september 10, 2010 was $5.33. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer's common stock.


Filed on 2010-09-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020699.txt Sec File: edgar/data/901430/0001225208-10-020699-index.htm

2010-09-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0.0000 remaining shares owned 12932718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 8, 2010, the reporting person settled a prepaid variable contract originally entered into on september 8, 2009. at the initiation of the contract, the bank paid $541,974.30 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 8, 2011. in addition, if the market price per share was equal to or greater than $13.524 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.524 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $11.27 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $11.27, the reporting person would deliver a fewer number of shares. the closing market price per share on september 8, 2010 was $5.15. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.


Filed on 2010-09-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020699.txt Sec File: edgar/data/901430/0001225208-10-020699-index.htm

2010-09-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-09-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020699.txt Sec File: edgar/data/901430/0001225208-10-020699-index.htm

2010-09-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020699.txt Sec File: edgar/data/901430/0001225208-10-020699-index.htm

2010-09-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-020699.txt Sec File: edgar/data/901430/0001225208-10-020699-index.htm

2010-09-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000.0000 shares at $0.0000 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-08 item expiration due date 2011-09-08 underlying security shares 60000.0000 underlying security title Common Stock

f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer?s common stock depending on the market price at maturity on september 8, 2011. in addition, if the market price per share was equal to or greater than $13.524 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.524 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $11.27 the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $11.27, the reporting person would deliver a fewer number of shares. the closing market price per share on september 8, 2010 was $5.15. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer?s common stock.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 8, 2010, the reporting person settled a prepaid variable contract originally entered into on september 8, 2009. at the initiation of the contract, the bank paid $541,974.30 to the reporting person.


Filed on 2010-09-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036501.txt Sec File: edgar/data/901430/0001140361-10-036501-index.htm

2010-09-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-09-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036501.txt Sec File: edgar/data/901430/0001140361-10-036501-index.htm

2010-09-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036501.txt Sec File: edgar/data/901430/0001140361-10-036501-index.htm

2010-09-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036501.txt Sec File: edgar/data/901430/0001140361-10-036501-index.htm

2010-09-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0 remaining shares owned 12992718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 105b-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 3, 2010, the reporting person settled a prepaid variable contract originally entered into on september 3, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $539,588.84 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer's common stock depending on market price at maturity on september 6, 2011. in addition, if the market price per share was equal to or greater than $13.4729 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.4729 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $11.2274, the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $11.2274 the reporting person would deliver a fewer number of shares. the closing market price per share on september 3, 2010 was $5.35. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer's common stock.


Filed on 2010-09-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036501.txt Sec File: edgar/data/901430/0001140361-10-036501-index.htm

2010-09-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-06 exercise price 0 has valueitem expiration due date 2011-09-06 underlying security shares 60000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 105b-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 3, 2010, the reporting person settled a prepaid variable contract originally entered into on september 3, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $539,588.84 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer's common stock depending on market price at maturity on september 6, 2011. in addition, if the market price per share was equal to or greater than $13.4729 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.4729 the contract would then be terminated and the reporting person would deliver shares to the bank pursuant to the early termination provision in the contract.
f3 upon early termination, if the market price per share was equal to or less than $11.2274, the reporting person would deliver 60,000 shares to the bank and if the market price per share was greater than $11.2274 the reporting person would deliver a fewer number of shares. the closing market price per share on september 3, 2010 was $5.35. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer's common stock.


Filed on 2010-09-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036372.txt Sec File: edgar/data/901430/0001140361-10-036372-index.htm

2010-09-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-09-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036372.txt Sec File: edgar/data/901430/0001140361-10-036372-index.htm

2010-09-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-02 exercise price 0 has valueitem expiration due date 2011-09-02 underlying security shares 60000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 105b-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 2, 2010, the reporting person settled a prepaid variable contract originally entered into on september 2, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $530,727.63 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer's common stock depending on market price at maturity on september 11, 2011. in addition, if the market price per share was equal to or greater than $13.26 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.26 the contract would then be terminated and the reporting person would deliver shares to the bank.
f3 if the market price per share upon an early termination was equal to or less than $11.0513 the reporting person would deliver 60,000 shares to the bank. if the market price per share upon an early termination was greater than $11.0513, the reporting person would deliver a fewer number of shares. the closing market price per share on september 2, 2010 was $5.31. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer's common stock.


Filed on 2010-09-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036372.txt Sec File: edgar/data/901430/0001140361-10-036372-index.htm

2010-09-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 60000 shares at $0 remaining shares owned 13052718

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on august 26, 2009, the reporting person entered into a rule 105b-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. on september 2, 2010, the reporting person settled a prepaid variable contract originally entered into on september 2, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $530,727.63 to the reporting person.
f2 under the contract reported on this form, the reporting person was obligated to deliver to the bank up to 60,000 shares of the issuer's common stock depending on market price at maturity on september 11, 2011. in addition, if the market price per share was equal to or greater than $13.26 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the first anniversary. if the market price per share on the first anniversary of the contract date was less than $13.26 the contract would then be terminated and the reporting person would deliver shares to the bank.
f3 if the market price per share upon an early termination was equal to or less than $11.0513 the reporting person would deliver 60,000 shares to the bank. if the market price per share upon an early termination was greater than $11.0513, the reporting person would deliver a fewer number of shares. the closing market price per share on september 2, 2010 was $5.31. accordingly, the reporting person transferred to the bank 60,000 shares of the issuer's common stock.


Filed on 2010-09-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036372.txt Sec File: edgar/data/901430/0001140361-10-036372-index.htm

2010-09-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-09-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-036372.txt Sec File: edgar/data/901430/0001140361-10-036372-index.htm

2010-09-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-08-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001140361-10-035542.txt Sec File: edgar/data/901430/0001140361-10-035542-index.htm

2010-08-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 486090 shares at $0 remaining shares owned 486090

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-08-27 exercise price 0 has valueitem expiration due date 2012-08-27 underlying security shares 486090 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a rule 105b-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 486,090 shares of the issuer's common stock depending on market prices at maturity on august 27, 2012. if the market price per share at maturity is equal to or less than the floor price of $5.3650 per share, the reporting person will deliver 486,090 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $1,773,353.54 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 486,090 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-08-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019538.txt Sec File: edgar/data/901430/0001225208-10-019538-index.htm

2010-08-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13112718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-08-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019538.txt Sec File: edgar/data/901430/0001225208-10-019538-index.htm

2010-08-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-08-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019538.txt Sec File: edgar/data/901430/0001225208-10-019538-index.htm

2010-08-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-08-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019538.txt Sec File: edgar/data/901430/0001225208-10-019538-index.htm

2010-08-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-08-17 item expiration due date 2012-08-17 underlying security shares 490000 underlying security title Common Stock

f6 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on august 17, 2012. if the market price per share at maturity is equal to or less than the floor price of $5.4822 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $1,813,237.65 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-08-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019538.txt Sec File: edgar/data/901430/0001225208-10-019538-index.htm

2010-08-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 4200 shares at $5.524 remaining shares owned 50000

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $5.84 to $5.43. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-08-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019367.txt Sec File: edgar/data/901430/0001225208-10-019367-index.htm

2010-08-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-08-13 item expiration due date 2012-08-13 underlying security shares 490000 underlying security title Common Stock

f6 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on august 13, 2012. if the market price per share at maturity is equal to or less than the floor price of $5.4895 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $1,803,547.78 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-08-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019367.txt Sec File: edgar/data/901430/0001225208-10-019367-index.htm

2010-08-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $5.4901 remaining shares owned 104200

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $5.57 to $5.43. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-08-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019367.txt Sec File: edgar/data/901430/0001225208-10-019367-index.htm

2010-08-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-08-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019367.txt Sec File: edgar/data/901430/0001225208-10-019367-index.htm

2010-08-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-08-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-019367.txt Sec File: edgar/data/901430/0001225208-10-019367-index.htm

2010-08-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13112718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-08-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018945.txt Sec File: edgar/data/901430/0001225208-10-018945-index.htm

2010-08-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-08-06 item expiration due date 2012-08-06 underlying security shares 490000 underlying security title Common Stock

f6 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on august 6, 2012. if the market price per share at maturity is equal to or less than the floor price of $5.7051 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $1,910,723.57 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-08-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018945.txt Sec File: edgar/data/901430/0001225208-10-018945-index.htm

2010-08-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $5.7375 remaining shares owned 13112718

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $5.82 to $5.64. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2010-08-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018945.txt Sec File: edgar/data/901430/0001225208-10-018945-index.htm

2010-08-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-08-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018945.txt Sec File: edgar/data/901430/0001225208-10-018945-index.htm

2010-08-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-08-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018945.txt Sec File: edgar/data/901430/0001225208-10-018945-index.htm

2010-08-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 354200

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-08-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018017.txt Sec File: edgar/data/901430/0001225208-10-018017-index.htm

2010-07-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-07-30 item expiration due date 2012-07-30 underlying security shares 490000 underlying security title Common Stock

f6 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on july 30, 2012. if the market price per share at maturity is equal to or less than the floor price of $5.6063 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $1,879,556.93 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-08-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018017.txt Sec File: edgar/data/901430/0001225208-10-018017-index.htm

2010-07-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $5.6286 remaining shares owned 604200

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $5.71 to $5.57. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-08-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018017.txt Sec File: edgar/data/901430/0001225208-10-018017-index.htm

2010-07-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-08-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018017.txt Sec File: edgar/data/901430/0001225208-10-018017-index.htm

2010-07-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-08-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-018017.txt Sec File: edgar/data/901430/0001225208-10-018017-index.htm

2010-07-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-07-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017688.txt Sec File: edgar/data/901430/0001225208-10-017688-index.htm

2010-07-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-07-23 item expiration due date 2012-07-23 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on july 23, 2012. if the market price per share at maturity is equal to or less than the floor price of $5.9288 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,011,790.06 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-07-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017688.txt Sec File: edgar/data/901430/0001225208-10-017688-index.htm

2010-07-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-07-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017688.txt Sec File: edgar/data/901430/0001225208-10-017688-index.htm

2010-07-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-07-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017688.txt Sec File: edgar/data/901430/0001225208-10-017688-index.htm

2010-07-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-07-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017688.txt Sec File: edgar/data/901430/0001225208-10-017688-index.htm

2010-07-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 12749 shares at $5.9343 remaining shares owned 879200

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $5.99 to $5.91. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-07-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017688.txt Sec File: edgar/data/901430/0001225208-10-017688-index.htm

2010-07-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $5.9333 remaining shares owned 829200

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $5.98 to $5.88. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-07-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017385.txt Sec File: edgar/data/901430/0001225208-10-017385-index.htm

2010-07-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-07-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017385.txt Sec File: edgar/data/901430/0001225208-10-017385-index.htm

2010-07-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-07-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017385.txt Sec File: edgar/data/901430/0001225208-10-017385-index.htm

2010-07-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-07-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017385.txt Sec File: edgar/data/901430/0001225208-10-017385-index.htm

2010-07-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $6.2204 remaining shares owned 1241949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.47 to $6.15. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-07-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017385.txt Sec File: edgar/data/901430/0001225208-10-017385-index.htm

2010-07-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $6.2443 remaining shares owned 1191949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.58 to $6.12. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-07-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-017385.txt Sec File: edgar/data/901430/0001225208-10-017385-index.htm

2010-07-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-07-16 item expiration due date 2012-07-16 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on july 16, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.2393 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,147,723.04 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-07-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-016972.txt Sec File: edgar/data/901430/0001225208-10-016972-index.htm

2010-07-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-07-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-016972.txt Sec File: edgar/data/901430/0001225208-10-016972-index.htm

2010-07-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-07-06 item expiration due date 2012-07-06 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on july 6, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.1070 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,091,708.57 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-07-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-016972.txt Sec File: edgar/data/901430/0001225208-10-016972-index.htm

2010-07-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $6.1025 remaining shares owned 1791949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.23 to $6.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-07-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-016972.txt Sec File: edgar/data/901430/0001225208-10-016972-index.htm

2010-07-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $6.119 remaining shares owned 1841949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.20 to $6.02. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-07-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-016972.txt Sec File: edgar/data/901430/0001225208-10-016972-index.htm

2010-07-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-07-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-016972.txt Sec File: edgar/data/901430/0001225208-10-016972-index.htm

2010-07-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-06-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015853.txt Sec File: edgar/data/901430/0001225208-10-015853-index.htm

2010-06-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015853.txt Sec File: edgar/data/901430/0001225208-10-015853-index.htm

2010-06-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-06-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015853.txt Sec File: edgar/data/901430/0001225208-10-015853-index.htm

2010-06-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015853.txt Sec File: edgar/data/901430/0001225208-10-015853-index.htm

2010-06-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $6.083 remaining shares owned 2216949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.15 to $6.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-06-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015853.txt Sec File: edgar/data/901430/0001225208-10-015853-index.htm

2010-06-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $6.0654 remaining shares owned 2166949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.15 to $6.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-06-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015853.txt Sec File: edgar/data/901430/0001225208-10-015853-index.htm

2010-06-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-28 item expiration due date 2012-06-28 underlying security shares 490000 underlying security title Common Stock

f6 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on june 28, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.0304 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,080,246.78 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-06-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015788.txt Sec File: edgar/data/901430/0001225208-10-015788-index.htm

2010-06-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-25 item expiration due date 2012-06-25 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on june 25, 2012. if the market price per share at maturity is equal to or less than the floor price of $5.9934 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,058,672.97 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-06-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015788.txt Sec File: edgar/data/901430/0001225208-10-015788-index.htm

2010-06-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015788.txt Sec File: edgar/data/901430/0001225208-10-015788-index.htm

2010-06-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015788.txt Sec File: edgar/data/901430/0001225208-10-015788-index.htm

2010-06-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-06-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015788.txt Sec File: edgar/data/901430/0001225208-10-015788-index.htm

2010-06-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $5.9927 remaining shares owned 2316949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.07 to $5.91. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-06-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015788.txt Sec File: edgar/data/901430/0001225208-10-015788-index.htm

2010-06-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $5.9884 remaining shares owned 2366949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.05 to $5.95. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-06-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015515.txt Sec File: edgar/data/901430/0001225208-10-015515-index.htm

2010-06-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015515.txt Sec File: edgar/data/901430/0001225208-10-015515-index.htm

2010-06-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $6.0712 remaining shares owned 2816949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.10 to $6.06. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-06-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015515.txt Sec File: edgar/data/901430/0001225208-10-015515-index.htm

2010-06-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $6.0639 remaining shares owned 2766949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.12 to $6.01. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-06-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015515.txt Sec File: edgar/data/901430/0001225208-10-015515-index.htm

2010-06-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-18 item expiration due date 2012-06-18 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on june 18, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.0584 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,048,345.04 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-06-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015515.txt Sec File: edgar/data/901430/0001225208-10-015515-index.htm

2010-06-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-06-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-015515.txt Sec File: edgar/data/901430/0001225208-10-015515-index.htm

2010-06-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014946.txt Sec File: edgar/data/901430/0001225208-10-014946-index.htm

2010-06-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $5.494 remaining shares owned 3266949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $5.515 to $5.45. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-06-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014946.txt Sec File: edgar/data/901430/0001225208-10-014946-index.htm

2010-06-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014946.txt Sec File: edgar/data/901430/0001225208-10-014946-index.htm

2010-06-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-06-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014946.txt Sec File: edgar/data/901430/0001225208-10-014946-index.htm

2010-06-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-08 item expiration due date 2012-06-08 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on june 8, 2012. if the market price per share at maturity is equal to or less than the floor price of $5.4855 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $1,804,921.49 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-06-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014946.txt Sec File: edgar/data/901430/0001225208-10-014946-index.htm

2010-06-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $5.4889 remaining shares owned 3216949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $5.58 to $5.41. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-06-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014946.txt Sec File: edgar/data/901430/0001225208-10-014946-index.htm

2010-06-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014756.txt Sec File: edgar/data/901430/0001225208-10-014756-index.htm

2010-06-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-06-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014756.txt Sec File: edgar/data/901430/0001225208-10-014756-index.htm

2010-06-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014756.txt Sec File: edgar/data/901430/0001225208-10-014756-index.htm

2010-06-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-06-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014756.txt Sec File: edgar/data/901430/0001225208-10-014756-index.htm

2010-06-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-06-01 item expiration due date 2012-06-01 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on june 1, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.0680 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,005,504.34 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-06-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014756.txt Sec File: edgar/data/901430/0001225208-10-014756-index.htm

2010-06-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $6.0614 remaining shares owned 3516949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.12 to $5.97. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-06-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014756.txt Sec File: edgar/data/901430/0001225208-10-014756-index.htm

2010-06-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $6.0552 remaining shares owned 3566949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.12 to $6.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-05-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014212.txt Sec File: edgar/data/901430/0001225208-10-014212-index.htm

2010-05-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $6.0999 remaining shares owned 3866949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.14 to $6.05. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-05-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014212.txt Sec File: edgar/data/901430/0001225208-10-014212-index.htm

2010-05-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-05-25 exercise price 0 has valueitem expiration due date 2012-05-25 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on may 25, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.0965 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,001,480.95 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-05-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014212.txt Sec File: edgar/data/901430/0001225208-10-014212-index.htm

2010-05-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $6.0959 remaining shares owned 3816949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.17 to $6.04. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-05-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014212.txt Sec File: edgar/data/901430/0001225208-10-014212-index.htm

2010-05-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-05-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014212.txt Sec File: edgar/data/901430/0001225208-10-014212-index.htm

2010-05-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-05-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-014212.txt Sec File: edgar/data/901430/0001225208-10-014212-index.htm

2010-05-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-05-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-013618.txt Sec File: edgar/data/901430/0001225208-10-013618-index.htm

2010-05-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $6.7096 remaining shares owned 4316949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.835 to $6.66. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-05-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-013618.txt Sec File: edgar/data/901430/0001225208-10-013618-index.htm

2010-05-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $6.6722 remaining shares owned 4266949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.84 to $6.65. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-05-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-013618.txt Sec File: edgar/data/901430/0001225208-10-013618-index.htm

2010-05-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-05-18 item expiration due date 2012-05-18 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on may 18, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.7002 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,298,168.60 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-05-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-013618.txt Sec File: edgar/data/901430/0001225208-10-013618-index.htm

2010-05-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx


Filed on 2010-05-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-013618.txt Sec File: edgar/data/901430/0001225208-10-013618-index.htm

2010-05-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-05-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-013618.txt Sec File: edgar/data/901430/0001225208-10-013618-index.htm

2010-05-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-05-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-012844.txt Sec File: edgar/data/901430/0001225208-10-012844-index.htm

2010-05-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-05-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-012844.txt Sec File: edgar/data/901430/0001225208-10-012844-index.htm

2010-05-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 18997 shares at $0 remaining shares owned 13162718

Common Stock Boston Scientific Corp Bsx Transaction code: A Grant, award, or other acquisition

f1 annual grant of restricted stock vesting upon the expiration of non-employee director's current term of office. reflects a value of $125,000 divided by the closing price of common stock on the date of the grant.


Filed on 2010-05-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-012844.txt Sec File: edgar/data/901430/0001225208-10-012844-index.htm

2010-05-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-05-11 item expiration due date 2012-05-11 underlying security shares 490000 underlying security title Common Stock

f5 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on may 11, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.5618 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,234,620.99 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f6 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-05-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-012844.txt Sec File: edgar/data/901430/0001225208-10-012844-index.htm

2010-05-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4416949

Common Stock Boston Scientific Corp Bsx

f2 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-05-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-012844.txt Sec File: edgar/data/901430/0001225208-10-012844-index.htm

2010-05-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-05-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-012449.txt Sec File: edgar/data/901430/0001225208-10-012449-index.htm

2010-05-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-05-04 item expiration due date 2012-05-04 underlying security shares 490000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on may 4, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.7636 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,253,631.52 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-05-03 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-011647.txt Sec File: edgar/data/901430/0001225208-10-011647-index.htm

2010-04-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-04-30 item expiration due date 2012-04-30 underlying security shares 490000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on april 30, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.9750 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,430,020.25 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010843.txt Sec File: edgar/data/901430/0001225208-10-010843-index.htm

2010-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f6 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010843.txt Sec File: edgar/data/901430/0001225208-10-010843-index.htm

2010-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-04-21 item expiration due date 2010-04-21 underlying security shares 100000 underlying security title Common Stock

f1 on april 21, 2010, the reporting person settled a prepaid variable forward sale contract entered into on april 21, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $635,296.12 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.53 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on april 21, 2010 was less than $8.53. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010843.txt Sec File: edgar/data/901430/0001225208-10-010843-index.htm

2010-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 13143721

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on april 21, 2010, the reporting person settled a prepaid variable forward sale contract entered into on april 21, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $635,296.12 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.53 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on april 21, 2010 was less than $8.53. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010843.txt Sec File: edgar/data/901430/0001225208-10-010843-index.htm

2010-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f7 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010843.txt Sec File: edgar/data/901430/0001225208-10-010843-index.htm

2010-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $7.2439 remaining shares owned 4866949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f5 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.35 to $7.16. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010843.txt Sec File: edgar/data/901430/0001225208-10-010843-index.htm

2010-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $7.2442 remaining shares owned 4916949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.34 to $7.19. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010720.txt Sec File: edgar/data/901430/0001225208-10-010720-index.htm

2010-04-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13243721

Common Stock Boston Scientific Corp Bsx


Filed on 2010-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010720.txt Sec File: edgar/data/901430/0001225208-10-010720-index.htm

2010-04-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-04-19 item expiration due date 2012-04-19 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on april 19, 2012. if the market price per share at maturity is equal to or less than the floor price of $7.3347 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,566,477.54 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010720.txt Sec File: edgar/data/901430/0001225208-10-010720-index.htm

2010-04-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $7.3489 remaining shares owned 5016949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.43 to $7.24. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010720.txt Sec File: edgar/data/901430/0001225208-10-010720-index.htm

2010-04-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010720.txt Sec File: edgar/data/901430/0001225208-10-010720-index.htm

2010-04-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $7.3546 remaining shares owned 5066949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.41 to $7.30. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010720.txt Sec File: edgar/data/901430/0001225208-10-010720-index.htm

2010-04-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010384.txt Sec File: edgar/data/901430/0001225208-10-010384-index.htm

2010-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 13243721

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on april 13, 2010, the reporting person settled a prepaid variable forward sale contract entered into on april 13, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $645,995.24 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.77 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on april 13, 2010 was less than $8.77. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010384.txt Sec File: edgar/data/901430/0001225208-10-010384-index.htm

2010-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $6.9052 remaining shares owned 5316949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f5 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.96 to $6.84. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010384.txt Sec File: edgar/data/901430/0001225208-10-010384-index.htm

2010-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $6.9092 remaining shares owned 5366949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.96 to $6.86. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010384.txt Sec File: edgar/data/901430/0001225208-10-010384-index.htm

2010-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f7 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010384.txt Sec File: edgar/data/901430/0001225208-10-010384-index.htm

2010-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f6 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010384.txt Sec File: edgar/data/901430/0001225208-10-010384-index.htm

2010-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-04-13 item expiration due date 2010-04-13 underlying security shares 100000 underlying security title Common Stock

f1 on april 13, 2010, the reporting person settled a prepaid variable forward sale contract entered into on april 13, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $645,995.24 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.77 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on april 13, 2010 was less than $8.77. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-04-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010328.txt Sec File: edgar/data/901430/0001225208-10-010328-index.htm

2010-04-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $7.0121 remaining shares owned 5391949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.05 to $6.94. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010328.txt Sec File: edgar/data/901430/0001225208-10-010328-index.htm

2010-04-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-04-12 item expiration due date 2012-04-12 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on april 12, 2012. if the market price per share at maturity is equal to or less than the floor price of $7.0382 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,452,383.37 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-04-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010328.txt Sec File: edgar/data/901430/0001225208-10-010328-index.htm

2010-04-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $7.0183 remaining shares owned 5441949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.06 to $6.99. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010328.txt Sec File: edgar/data/901430/0001225208-10-010328-index.htm

2010-04-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010328.txt Sec File: edgar/data/901430/0001225208-10-010328-index.htm

2010-04-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010328.txt Sec File: edgar/data/901430/0001225208-10-010328-index.htm

2010-04-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13343721

Common Stock Boston Scientific Corp Bsx


Filed on 2010-04-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010231.txt Sec File: edgar/data/901430/0001225208-10-010231-index.htm

2010-04-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $7.0357 remaining shares owned 5541949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.12 to $6.98. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010231.txt Sec File: edgar/data/901430/0001225208-10-010231-index.htm

2010-04-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-04-09 item expiration due date 2012-04-09 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on april 9, 2012. if the market price per share at maturity is equal to or less than the floor price of $7.0442 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,454,128.84 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-04-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010231.txt Sec File: edgar/data/901430/0001225208-10-010231-index.htm

2010-04-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13343721

Common Stock Boston Scientific Corp Bsx


Filed on 2010-04-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010231.txt Sec File: edgar/data/901430/0001225208-10-010231-index.htm

2010-04-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010231.txt Sec File: edgar/data/901430/0001225208-10-010231-index.htm

2010-04-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010231.txt Sec File: edgar/data/901430/0001225208-10-010231-index.htm

2010-04-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $7.0396 remaining shares owned 5591949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.08 to $7.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010155.txt Sec File: edgar/data/901430/0001225208-10-010155-index.htm

2010-04-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $7.1485 remaining shares owned 5691949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f5 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.21 to $7.09. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010155.txt Sec File: edgar/data/901430/0001225208-10-010155-index.htm

2010-04-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $7.1477 remaining shares owned 5741949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.20 to $7.10. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010155.txt Sec File: edgar/data/901430/0001225208-10-010155-index.htm

2010-04-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f6 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010155.txt Sec File: edgar/data/901430/0001225208-10-010155-index.htm

2010-04-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f7 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010155.txt Sec File: edgar/data/901430/0001225208-10-010155-index.htm

2010-04-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 13343721

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on april 6, 2010, the reporting person settled a prepaid variable forward sale contract entered into on april 6, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $616,863.40 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.40 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on april 6, 2010 was less than $8.40. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-04-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-010155.txt Sec File: edgar/data/901430/0001225208-10-010155-index.htm

2010-04-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-04-06 item expiration due date 2010-04-06 underlying security shares 100000 underlying security title Common Stock

f1 on april 6, 2010, the reporting person settled a prepaid variable forward sale contract entered into on april 6, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $616,863.40 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.40 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on april 6, 2010 was less than $8.40. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009370.txt Sec File: edgar/data/901430/0001225208-10-009370-index.htm

2010-03-31 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-03-30 item expiration due date 2012-03-30 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on march 30, 2012. if the market price per share at maturity is equal to or less than the floor price of $7.2230 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,509,696.36 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009370.txt Sec File: edgar/data/901430/0001225208-10-009370-index.htm

2010-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13443721

Common Stock Boston Scientific Corp Bsx


Filed on 2010-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009370.txt Sec File: edgar/data/901430/0001225208-10-009370-index.htm

2010-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009370.txt Sec File: edgar/data/901430/0001225208-10-009370-index.htm

2010-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009370.txt Sec File: edgar/data/901430/0001225208-10-009370-index.htm

2010-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $7.144 remaining shares owned 6041949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.26 to $7.05. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009370.txt Sec File: edgar/data/901430/0001225208-10-009370-index.htm

2010-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $7.1314 remaining shares owned 5991949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.25 to $7.01. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-03-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009178.txt Sec File: edgar/data/901430/0001225208-10-009178-index.htm

2010-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-03-30 item expiration due date 2010-03-30 underlying security shares 100000 underlying security title Common Stock

f1 on march 30, 2010, the reporting person settled a prepaid variable forward sale contract entered into on march 30, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $577,836.79 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.92 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on march 30, 2010 was less than $7.92. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-03-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009178.txt Sec File: edgar/data/901430/0001225208-10-009178-index.htm

2010-03-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f6 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-03-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009178.txt Sec File: edgar/data/901430/0001225208-10-009178-index.htm

2010-03-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f7 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-03-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009178.txt Sec File: edgar/data/901430/0001225208-10-009178-index.htm

2010-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 13443721

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 30, 2010, the reporting person settled a prepaid variable forward sale contract entered into on march 30, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $577,836.79 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.92 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on march 30, 2010 was less than $7.92. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-03-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009178.txt Sec File: edgar/data/901430/0001225208-10-009178-index.htm

2010-03-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $7.0538 remaining shares owned 6116949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.17 to $7.03. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-03-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-009178.txt Sec File: edgar/data/901430/0001225208-10-009178-index.htm

2010-03-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $7.0399 remaining shares owned 6066949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f5 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.11 to $6.98. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-03-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008881.txt Sec File: edgar/data/901430/0001225208-10-008881-index.htm

2010-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-03-23 item expiration due date 2012-03-23 underlying security shares 490000 underlying security title Common Stock

f7 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on march 23, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.8654 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,425,477.17 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f8 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-03-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008881.txt Sec File: edgar/data/901430/0001225208-10-008881-index.htm

2010-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $6.9446 remaining shares owned 6416949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.06 to $6.87. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-03-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008881.txt Sec File: edgar/data/901430/0001225208-10-008881-index.htm

2010-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f6 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-03-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008881.txt Sec File: edgar/data/901430/0001225208-10-008881-index.htm

2010-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f5 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-03-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008881.txt Sec File: edgar/data/901430/0001225208-10-008881-index.htm

2010-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 13543721

Common Stock Boston Scientific Corp Bsx


Filed on 2010-03-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008881.txt Sec File: edgar/data/901430/0001225208-10-008881-index.htm

2010-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $6.8911 remaining shares owned 6366949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.05 to $6.82. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008856.txt Sec File: edgar/data/901430/0001225208-10-008856-index.htm

2010-03-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $7.0458 remaining shares owned 6441949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f5 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.12 to $6.98. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008856.txt Sec File: edgar/data/901430/0001225208-10-008856-index.htm

2010-03-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f6 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008856.txt Sec File: edgar/data/901430/0001225208-10-008856-index.htm

2010-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-03-23 item expiration due date 2010-03-23 underlying security shares 100000 underlying security title Common Stock

f1 on march 23, 2010, the reporting person settled a prepaid variable forward sale contract entered into on march 23, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $594,173.48 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.91 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on march 23, 2010 was less than $7.91. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008856.txt Sec File: edgar/data/901430/0001225208-10-008856-index.htm

2010-03-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 25000 shares at $7.0121 remaining shares owned 6491949

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.11 to $6.97. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f4 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008856.txt Sec File: edgar/data/901430/0001225208-10-008856-index.htm

2010-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 13543721

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 23, 2010, the reporting person settled a prepaid variable forward sale contract entered into on march 23, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $594,173.48 to the reporting person. the contract obligated the reporting person to deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.91 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on march 23, 2010 was less than $7.91. accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008856.txt Sec File: edgar/data/901430/0001225208-10-008856-index.htm

2010-03-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f7 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008570.txt Sec File: edgar/data/901430/0001225208-10-008570-index.htm

2010-03-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 13643721

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on march 16, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on march 16, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $568,335.21 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.73 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on march 16, 2010 was $7.09 accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008570.txt Sec File: edgar/data/901430/0001225208-10-008570-index.htm

2010-03-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $0 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-03-16 item expiration due date 2010-03-16 underlying security shares 100000 underlying security title Common Stock

f1 on march 16, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on march 16, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $568,335.21 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 100,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.73 per share, the reporting person would deliver 100,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on march 16, 2010 was $7.09 accordingly, the reporting person transferred to the bank 100,000 shares of the issuer's common stock.


Filed on 2010-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008570.txt Sec File: edgar/data/901430/0001225208-10-008570-index.htm

2010-03-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 6666949

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008570.txt Sec File: edgar/data/901430/0001225208-10-008570-index.htm

2010-03-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008570.txt Sec File: edgar/data/901430/0001225208-10-008570-index.htm

2010-03-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-03-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-008449.txt Sec File: edgar/data/901430/0001225208-10-008449-index.htm

2010-03-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 490000 shares at $0 remaining shares owned 490000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2012-03-15 item expiration due date 2012-03-15 underlying security shares 490000 underlying security title Common Stock

f1 on march 1, 2010, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the issuer's common stock depending on market prices at maturity on march 15, 2012. if the market price per share at maturity is equal to or less than the floor price of $6.6972 per share, the reporting person will deliver 490,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,364,412.97 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 490,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2010-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-003091.txt Sec File: edgar/data/901430/0001225208-10-003091-index.htm

2010-01-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 16172921

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on january 29, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 29, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $891,693.33 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.96 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 29, 2010 was $8.63. accordingly, the reporting person transferred to the bank 119,722 shares of the issuer's common stock.


Filed on 2010-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-003091.txt Sec File: edgar/data/901430/0001225208-10-003091-index.htm

2010-01-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-29 exercise price 0 has valueitem expiration due date 2010-01-29 underlying security shares 119722 underlying security title Common Stock

f1 on january 29, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 29, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $891,693.33 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.96 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 29, 2010 was $8.63. accordingly, the reporting person transferred to the bank 119,722 shares of the issuer's common stock.


Filed on 2010-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-003091.txt Sec File: edgar/data/901430/0001225208-10-003091-index.htm

2010-01-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-003091.txt Sec File: edgar/data/901430/0001225208-10-003091-index.htm

2010-01-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-003091.txt Sec File: edgar/data/901430/0001225208-10-003091-index.htm

2010-01-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002651.txt Sec File: edgar/data/901430/0001225208-10-002651-index.htm

2010-01-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-27 exercise price 0 has valueitem expiration due date 2010-01-27 underlying security shares 119722 underlying security title Common Stock

f1 on january 27, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 27, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $872,559.05 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.43 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 27, 2010 was $8.93. accordingly, the reporting person transferred to the bank 113,052 shares of the issuer's common stock and the bank returned 6,670 of the pledged shares to the reporting person.


Filed on 2010-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002651.txt Sec File: edgar/data/901430/0001225208-10-002651-index.htm

2010-01-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002651.txt Sec File: edgar/data/901430/0001225208-10-002651-index.htm

2010-01-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002651.txt Sec File: edgar/data/901430/0001225208-10-002651-index.htm

2010-01-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002651.txt Sec File: edgar/data/901430/0001225208-10-002651-index.htm

2010-01-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 113052 shares at $0 remaining shares owned 16292643

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on january 27, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 27, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $872,559.05 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $8.43 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 27, 2010 was $8.93. accordingly, the reporting person transferred to the bank 113,052 shares of the issuer's common stock and the bank returned 6,670 of the pledged shares to the reporting person.


Filed on 2010-01-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002272.txt Sec File: edgar/data/901430/0001225208-10-002272-index.htm

2010-01-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 101721 shares at $0 remaining shares owned 16405695

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on january 22, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 23, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $759,124.47 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.65 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 22, 2010 was $9.00. accordingly, the reporting person transferred to the bank 101,721 shares of the issuer's common stock and the bank returned 18,001 of the pledged shares to the reporting person.


Filed on 2010-01-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002272.txt Sec File: edgar/data/901430/0001225208-10-002272-index.htm

2010-01-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002272.txt Sec File: edgar/data/901430/0001225208-10-002272-index.htm

2010-01-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002272.txt Sec File: edgar/data/901430/0001225208-10-002272-index.htm

2010-01-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-01-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002272.txt Sec File: edgar/data/901430/0001225208-10-002272-index.htm

2010-01-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-22 exercise price 0 has valueitem expiration due date 2010-01-22 underlying security shares 119722 underlying security title Common Stock

f1 on january 22, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 23, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $759,124.47 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.65 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 22, 2010 was $9.00. accordingly, the reporting person transferred to the bank 101,721 shares of the issuer's common stock and the bank returned 18,001 of the pledged shares to the reporting person.


Filed on 2010-01-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002171.txt Sec File: edgar/data/901430/0001225208-10-002171-index.htm

2010-01-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002171.txt Sec File: edgar/data/901430/0001225208-10-002171-index.htm

2010-01-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 99805 shares at $0 remaining shares owned 16507416

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on january 21, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 21, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $790,656.96 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.65 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 21, 2010 was $9.20. accordingly, the reporting person transferred to the bank 99,805 shares of the issuer's common stock and the bank returned 19,917 of the pledged shares to the reporting person.


Filed on 2010-01-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002171.txt Sec File: edgar/data/901430/0001225208-10-002171-index.htm

2010-01-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-21 exercise price 0 has valueitem expiration due date 2010-01-21 underlying security shares 119722 underlying security title Common Stock

f1 on january 21, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 21, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $790,656.96 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.65 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 21, 2010 was $9.20. accordingly, the reporting person transferred to the bank 99,805 shares of the issuer's common stock and the bank returned 19,917 of the pledged shares to the reporting person.


Filed on 2010-01-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002171.txt Sec File: edgar/data/901430/0001225208-10-002171-index.htm

2010-01-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-01-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-002171.txt Sec File: edgar/data/901430/0001225208-10-002171-index.htm

2010-01-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001906.txt Sec File: edgar/data/901430/0001225208-10-001906-index.htm

2010-01-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001906.txt Sec File: edgar/data/901430/0001225208-10-001906-index.htm

2010-01-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-15 exercise price 0 has valueitem expiration due date 2010-01-15 underlying security shares 119722 underlying security title Common Stock

f1 on january 15, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 15, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $726,946.53 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.32 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 15, 2010 was $9.43. accordingly, the reporting person transferred to the bank 92,946 shares of the issuer's common stock and the bank returned 26,776 of the pledged shares to the reporting person.


Filed on 2010-01-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001906.txt Sec File: edgar/data/901430/0001225208-10-001906-index.htm

2010-01-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 92946 shares at $0 remaining shares owned 16607221

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on january 15, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 15, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $726,946.53 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.32 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 15, 2010 was $9.43. accordingly, the reporting person transferred to the bank 92,946 shares of the issuer's common stock and the bank returned 26,776 of the pledged shares to the reporting person.


Filed on 2010-01-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001906.txt Sec File: edgar/data/901430/0001225208-10-001906-index.htm

2010-01-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001906.txt Sec File: edgar/data/901430/0001225208-10-001906-index.htm

2010-01-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-01-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001636.txt Sec File: edgar/data/901430/0001225208-10-001636-index.htm

2010-01-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001636.txt Sec File: edgar/data/901430/0001225208-10-001636-index.htm

2010-01-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-01-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001636.txt Sec File: edgar/data/901430/0001225208-10-001636-index.htm

2010-01-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-13 exercise price 0 has valueitem expiration due date 2010-01-13 underlying security shares 119722 underlying security title Common Stock

f1 on january 13, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 13, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $769,121.78 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.41 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 13, 2010 was $9.15. accordingly, the reporting person transferred to the bank 100,321 shares of the issuer's common stock and the bank returned 19,401 of the pledged shares to the reporting person.


Filed on 2010-01-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001636.txt Sec File: edgar/data/901430/0001225208-10-001636-index.htm

2010-01-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100321 shares at $0 remaining shares owned 16700167

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on january 13, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 13, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $769,121.78 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.41 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 13, 2010 was $9.15. accordingly, the reporting person transferred to the bank 100,321 shares of the issuer's common stock and the bank returned 19,401 of the pledged shares to the reporting person.


Filed on 2010-01-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001636.txt Sec File: edgar/data/901430/0001225208-10-001636-index.htm

2010-01-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001419.txt Sec File: edgar/data/901430/0001225208-10-001419-index.htm

2010-01-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001419.txt Sec File: edgar/data/901430/0001225208-10-001419-index.htm

2010-01-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001419.txt Sec File: edgar/data/901430/0001225208-10-001419-index.htm

2010-01-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-08 exercise price 0 has valueitem expiration due date 2010-01-08 underlying security shares 119722 underlying security title Common Stock

f1 on january 8, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 9, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $764,627.92 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.71 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 8, 2010 was $9.00. accordingly, the reporting person transferred to the bank 102,607 shares of the issuer's common stock and the bank returned 17,115 of the pledged shares to the reporting person.


Filed on 2010-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001419.txt Sec File: edgar/data/901430/0001225208-10-001419-index.htm

2010-01-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 102607 shares at $0 remaining shares owned 16800488

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on january 8, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 9, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $764,627.92 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.71 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 8, 2010 was $9.00. accordingly, the reporting person transferred to the bank 102,607 shares of the issuer's common stock and the bank returned 17,115 of the pledged shares to the reporting person.


Filed on 2010-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001419.txt Sec File: edgar/data/901430/0001225208-10-001419-index.htm

2010-01-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001236.txt Sec File: edgar/data/901430/0001225208-10-001236-index.htm

2010-01-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001236.txt Sec File: edgar/data/901430/0001225208-10-001236-index.htm

2010-01-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2010-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001236.txt Sec File: edgar/data/901430/0001225208-10-001236-index.htm

2010-01-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001236.txt Sec File: edgar/data/901430/0001225208-10-001236-index.htm

2010-01-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 102850 shares at $0 remaining shares owned 16903095

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on january 6, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 6, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $817,275.56 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.87 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 6, 2010 was $9.16. accordingly, the reporting person transferred to the bank 102,850 shares of the issuer's common stock and the bank returned 16,872 of the pledged shares to the reporting person.


Filed on 2010-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-001236.txt Sec File: edgar/data/901430/0001225208-10-001236-index.htm

2010-01-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-06 exercise price 0 has valueitem expiration due date 2010-01-06 underlying security shares 119722 underlying security title Common Stock

f1 on january 6, 2010, the reporting person settled a prepaid variable forward sale contract originally entered into on january 6, 2009 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $817,275.56 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.87 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on january 6, 2010 was $9.16. accordingly, the reporting person transferred to the bank 102,850 shares of the issuer's common stock and the bank returned 16,872 of the pledged shares to the reporting person.


Filed on 2010-01-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-000241.txt Sec File: edgar/data/901430/0001225208-10-000241-index.htm

2009-12-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-30 exercise price 0 has valueitem expiration due date 2009-12-30 underlying security shares 119722 underlying security title Common Stock

f1 on december 30, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 30, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $723,988.86 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.33 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 30, 2009 was $9.05. accordingly, the reporting person transferred to the bank 96,968 shares of the issuer's common stock and the bank returned 22,754 of the pledged shares to the reporting person.


Filed on 2010-01-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-000241.txt Sec File: edgar/data/901430/0001225208-10-000241-index.htm

2009-12-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 96968 shares at $0 remaining shares owned 17005945

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on december 30, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 30, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $723,988.86 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.33 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 30, 2009 was $9.05. accordingly, the reporting person transferred to the bank 96,968 shares of the issuer's common stock and the bank returned 22,754 of the pledged shares to the reporting person.


Filed on 2010-01-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-000241.txt Sec File: edgar/data/901430/0001225208-10-000241-index.htm

2009-12-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-000241.txt Sec File: edgar/data/901430/0001225208-10-000241-index.htm

2009-12-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2010-01-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-10-000241.txt Sec File: edgar/data/901430/0001225208-10-000241-index.htm

2009-12-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2009-12-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025199.txt Sec File: edgar/data/901430/0001225208-09-025199-index.htm

2009-12-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 99866 shares at $0 remaining shares owned 17102913

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on december 29, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 29, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $759,381.59 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.314 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 29, 2009 was $8.82. accordingly, the reporting person transferred to the bank 99,866 shares of the issuer's common stock and the bank returned 19,856 of the pledged shares to the reporting person.


Filed on 2009-12-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025199.txt Sec File: edgar/data/901430/0001225208-09-025199-index.htm

2009-12-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-29 exercise price 0 has valueitem expiration due date 2009-12-29 underlying security shares 119722 underlying security title Common Stock

f1 on december 29, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 29, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $759,381.59 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.314 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 29, 2009 was $8.82. accordingly, the reporting person transferred to the bank 99,866 shares of the issuer's common stock and the bank returned 19,856 of the pledged shares to the reporting person.


Filed on 2009-12-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025199.txt Sec File: edgar/data/901430/0001225208-09-025199-index.htm

2009-12-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2009-12-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025199.txt Sec File: edgar/data/901430/0001225208-09-025199-index.htm

2009-12-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-31 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025199.txt Sec File: edgar/data/901430/0001225208-09-025199-index.htm

2009-12-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025056.txt Sec File: edgar/data/901430/0001225208-09-025056-index.htm

2009-12-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-23 exercise price 0 has valueitem expiration due date 2009-12-23 underlying security shares 119722 underlying security title Common Stock

f1 on december 23, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 23, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $742,364.59 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.49 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 23, 2009 was $8.82. accordingly, the reporting person transferred to the bank 101,616 shares of the issuer's common stock and the bank returned 18,106 of the pledged shares to the reporting person.


Filed on 2009-12-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025056.txt Sec File: edgar/data/901430/0001225208-09-025056-index.htm

2009-12-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 101616 shares at $0 remaining shares owned 17202779

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on december 23, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 23, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $742,364.59 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.49 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 23, 2009 was $8.82. accordingly, the reporting person transferred to the bank 101,616 shares of the issuer's common stock and the bank returned 18,106 of the pledged shares to the reporting person.


Filed on 2009-12-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025056.txt Sec File: edgar/data/901430/0001225208-09-025056-index.htm

2009-12-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025056.txt Sec File: edgar/data/901430/0001225208-09-025056-index.htm

2009-12-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-025056.txt Sec File: edgar/data/901430/0001225208-09-025056-index.htm

2009-12-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2009-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024955.txt Sec File: edgar/data/901430/0001225208-09-024955-index.htm

2009-12-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024955.txt Sec File: edgar/data/901430/0001225208-09-024955-index.htm

2009-12-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2009-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024955.txt Sec File: edgar/data/901430/0001225208-09-024955-index.htm

2009-12-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-22 exercise price 0 has valueitem expiration due date 2009-12-22 underlying security shares 119722 underlying security title Common Stock

f1 on december 22, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 22, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $745,567.64 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.52 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 22, 2009 was $8.80. accordingly, the reporting person transferred to the bank 102,286 shares of the issuer's common stock and the bank returned 17,436 of the pledged shares to the reporting person.


Filed on 2009-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024955.txt Sec File: edgar/data/901430/0001225208-09-024955-index.htm

2009-12-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 102286 shares at $0 remaining shares owned 17304395

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on december 22, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 22, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $745,567.64 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.52 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 22, 2009 was $8.80. accordingly, the reporting person transferred to the bank 102,286 shares of the issuer's common stock and the bank returned 17,436 of the pledged shares to the reporting person.


Filed on 2009-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024955.txt Sec File: edgar/data/901430/0001225208-09-024955-index.htm

2009-12-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024878.txt Sec File: edgar/data/901430/0001225208-09-024878-index.htm

2009-12-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2009-12-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024878.txt Sec File: edgar/data/901430/0001225208-09-024878-index.htm

2009-12-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-18 exercise price 0 has valueitem expiration due date 2009-12-18 underlying security shares 119722 underlying security title Common Stock

f1 on december 18, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 19, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $757,171.49 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.71 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 18, 2009 was $8.90. accordingly, the reporting person transferred to the bank 103,751 shares of the issuer's common stock and the bank returned 15,971 of the pledged shares to the reporting person.


Filed on 2009-12-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024878.txt Sec File: edgar/data/901430/0001225208-09-024878-index.htm

2009-12-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 103751 shares at $0 remaining shares owned 17406681

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on december 18, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 19, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $757,171.49 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.71 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 18, 2009 was $8.90. accordingly, the reporting person transferred to the bank 103,751 shares of the issuer's common stock and the bank returned 15,971 of the pledged shares to the reporting person.


Filed on 2009-12-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024878.txt Sec File: edgar/data/901430/0001225208-09-024878-index.htm

2009-12-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024878.txt Sec File: edgar/data/901430/0001225208-09-024878-index.htm

2009-12-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024749.txt Sec File: edgar/data/901430/0001225208-09-024749-index.htm

2009-12-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-17 exercise price 0 has valueitem expiration due date 2009-12-17 underlying security shares 119722 underlying security title Common Stock

f1 on december 17, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 17, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $741,168.83 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.5543 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 17, 2009 was $8.70. accordingly, the reporting person transferred to the bank 103,956 shares of the issuer's common stock and the bank returned 15,766 of the pledged shares to the reporting person.


Filed on 2009-12-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024749.txt Sec File: edgar/data/901430/0001225208-09-024749-index.htm

2009-12-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2009-12-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024749.txt Sec File: edgar/data/901430/0001225208-09-024749-index.htm

2009-12-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 103956 shares at $0 remaining shares owned 17510432

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on december 17, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 17, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $741,168.83 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.5543 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 17, 2009 was $8.70. accordingly, the reporting person transferred to the bank 103,956 shares of the issuer's common stock and the bank returned 15,766 of the pledged shares to the reporting person.


Filed on 2009-12-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024749.txt Sec File: edgar/data/901430/0001225208-09-024749-index.htm

2009-12-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024749.txt Sec File: edgar/data/901430/0001225208-09-024749-index.htm

2009-12-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024520.txt Sec File: edgar/data/901430/0001225208-09-024520-index.htm

2009-12-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 98299 shares at $0 remaining shares owned 17614388

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on december 11, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 12, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $694,074.87 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.12 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 11, 2009 was $8.67. accordingly, the reporting person transferred to the bank 98,299 shares of the issuer's common stock and the bank returned 21,423 of the pledged shares to the reporting person.


Filed on 2009-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024520.txt Sec File: edgar/data/901430/0001225208-09-024520-index.htm

2009-12-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024520.txt Sec File: edgar/data/901430/0001225208-09-024520-index.htm

2009-12-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024520.txt Sec File: edgar/data/901430/0001225208-09-024520-index.htm

2009-12-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-11 exercise price 0 has valueitem expiration due date 2009-12-11 underlying security shares 119722 underlying security title Common Stock

f1 on december 11, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 12, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $694,074.87 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.12 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 11, 2009 was $8.67. accordingly, the reporting person transferred to the bank 98,299 shares of the issuer's common stock and the bank returned 21,423 of the pledged shares to the reporting person.


Filed on 2009-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024520.txt Sec File: edgar/data/901430/0001225208-09-024520-index.htm

2009-12-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2009-12-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024478.txt Sec File: edgar/data/901430/0001225208-09-024478-index.htm

2009-12-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2009-12-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024478.txt Sec File: edgar/data/901430/0001225208-09-024478-index.htm

2009-12-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024478.txt Sec File: edgar/data/901430/0001225208-09-024478-index.htm

2009-12-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 99999 shares at $0 remaining shares owned 17712687

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on december 10, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 10, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $709,978.48 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.28 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 10, 2009 was $8.72. accordingly, the reporting person transferred to the bank 99,999 shares of the issuer's common stock and the bank returned 19,723 of the pledged shares to the reporting person.


Filed on 2009-12-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024478.txt Sec File: edgar/data/901430/0001225208-09-024478-index.htm

2009-12-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 119722 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-10 exercise price 0 has valueitem expiration due date 2009-12-10 underlying security shares 119722 underlying security title Common Stock

f1 on december 10, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 10, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $709,978.48 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 119,722 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $7.28 per share, the reporting person would deliver 119,722 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 10, 2009 was $8.72. accordingly, the reporting person transferred to the bank 99,999 shares of the issuer's common stock and the bank returned 19,723 of the pledged shares to the reporting person.


Filed on 2009-12-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024478.txt Sec File: edgar/data/901430/0001225208-09-024478-index.htm

2009-12-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024179.txt Sec File: edgar/data/901430/0001225208-09-024179-index.htm

2009-12-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 422095 shares at $0 remaining shares owned 17812686

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 on december 4, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 4, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $2,850,720.35 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 500,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $6.637 per share, the reporting person would deliver 500,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 4, 2009 was $8.52. accordingly, the reporting person transferred to the bank 422,095 shares of the issuer's common stock and the bank returned 77,905 of the pledged shares to the reporting person.


Filed on 2009-12-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024179.txt Sec File: edgar/data/901430/0001225208-09-024179-index.htm

2009-12-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx

f3 common stock held by a limited liability company of which reporting person holds 100% membership interest.


Filed on 2009-12-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024179.txt Sec File: edgar/data/901430/0001225208-09-024179-index.htm

2009-12-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024179.txt Sec File: edgar/data/901430/0001225208-09-024179-index.htm

2009-12-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-12-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-024179.txt Sec File: edgar/data/901430/0001225208-09-024179-index.htm

2009-12-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 500000 shares at $0 remaining shares owned 0

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-04 exercise price 0 has valueitem expiration due date 2009-12-04 underlying security shares 500000 underlying security title Common Stock

f1 on december 4, 2009, the reporting person settled a prepaid variable forward sale contract originally entered into on december 4, 2008 with an unaffiliated commercial bank. at the initiation of the contract, the bank paid $2,850,720.35 to the reporting person.
f2 the forward sale contract obligated the reporting person to deliver to the bank at maturity up to 500,000 shares of the issuer's common stock depending on market prices at maturity. if the market price per share at maturity was equal to or less than the floor price of $6.637 per share, the reporting person would deliver 500,000 shares to the bank. if the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. the market price per share on december 4, 2009 was $8.52. accordingly, the reporting person transferred to the bank 422,095 shares of the issuer's common stock and the bank returned 77,905 of the pledged shares to the reporting person.


Filed on 2009-11-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021676.txt Sec File: edgar/data/901430/0001225208-09-021676-index.htm

2009-11-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 18234781

Common Stock Boston Scientific Corp Bsx


Filed on 2009-11-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021676.txt Sec File: edgar/data/901430/0001225208-09-021676-index.htm

2009-11-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 225000 shares at $0 remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 a limited liability company of which the reporting person holds 100% membership interest entered into agreements to sell 100,000 shares on october 28, 2009 and 125,000 shares on october 29, 2009. on november 2, 2009, these sale agreements were rescinded.
f2 shares held by a limited liability company of which the reporting person holds 100% membership interest.


Filed on 2009-11-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021676.txt Sec File: edgar/data/901430/0001225208-09-021676-index.htm

2009-11-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-11-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021676.txt Sec File: edgar/data/901430/0001225208-09-021676-index.htm

2009-11-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $0 remaining shares owned 0

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-28 exercise price 0 has valueitem expiration due date 2010-10-28 underlying security shares 50000 underlying security title Common Stock

f5 on october 28, 2009, the reporting person entered into a prepaid forward sales contract with an unaffiliated commercial bank. on november 2, 2009, the sales contract was rescinded.


Filed on 2009-11-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021676.txt Sec File: edgar/data/901430/0001225208-09-021676-index.htm

2009-11-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-10-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021179.txt Sec File: edgar/data/901430/0001225208-09-021179-index.htm

2009-10-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-10-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021179.txt Sec File: edgar/data/901430/0001225208-09-021179-index.htm

2009-10-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-10-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021179.txt Sec File: edgar/data/901430/0001225208-09-021179-index.htm

2009-10-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $8.2396 remaining shares owned 4187749

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.41 to $8.13. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f2 shares held by a limited liability company of which the reporting person holds 100% membership interest.


Filed on 2009-10-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021179.txt Sec File: edgar/data/901430/0001225208-09-021179-index.htm

2009-10-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $8.2215 remaining shares owned 4137749

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.41 to $8.16. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f2 shares held by a limited liability company of which the reporting person holds 100% membership interest.


Filed on 2009-10-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021179.txt Sec File: edgar/data/901430/0001225208-09-021179-index.htm

2009-10-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-28 exercise price 0 has valueitem expiration due date 2010-10-28 underlying security shares 50000 underlying security title Common Stock

f6 under the variable prepaid forward sale contract reported on this form, the reporting person will deliver to an unaffiliated commercial bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 28, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.2404 per share, promerica will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, promerica will deliver a fewer number of shares but not less than 35,700 shares. in exchange, the bank is obligated to pay $349,598.97 to promerica two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021179.txt Sec File: edgar/data/901430/0001225208-09-021179-index.htm

2009-10-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 18234781

Common Stock Boston Scientific Corp Bsx


Filed on 2009-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021136.txt Sec File: edgar/data/901430/0001225208-09-021136-index.htm

2009-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021136.txt Sec File: edgar/data/901430/0001225208-09-021136-index.htm

2009-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021136.txt Sec File: edgar/data/901430/0001225208-09-021136-index.htm

2009-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $8.4436 remaining shares owned 4287749

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.58 to $8.36. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f2 shares held by a limited liability company of which the reporting person holds 100% membership interest.


Filed on 2009-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021136.txt Sec File: edgar/data/901430/0001225208-09-021136-index.htm

2009-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $8.4296 remaining shares owned 4237749

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.51 to $8.40. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f2 shares held by a limited liability company of which the reporting person holds 100% membership interest.


Filed on 2009-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021136.txt Sec File: edgar/data/901430/0001225208-09-021136-index.htm

2009-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-27 exercise price 0 has valueitem expiration due date 2010-10-27 underlying security shares 50000 underlying security title Common Stock

f6 under the variable prepaid forward sale contract reported on this form, the reporting person will deliver to an unaffiliated commercial bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 27, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.4193 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares but not less than 35,700 shares. in exchange, the bank is obligated to pay $357,820.25 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021136.txt Sec File: edgar/data/901430/0001225208-09-021136-index.htm

2009-10-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 18234781

Common Stock Boston Scientific Corp Bsx


Filed on 2009-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021076.txt Sec File: edgar/data/901430/0001225208-09-021076-index.htm

2009-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 18234781

Common Stock Boston Scientific Corp Bsx


Filed on 2009-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021076.txt Sec File: edgar/data/901430/0001225208-09-021076-index.htm

2009-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021076.txt Sec File: edgar/data/901430/0001225208-09-021076-index.htm

2009-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $8.7467 remaining shares owned 4387749

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.77 to $8.70. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f2 shares held by a limited liability company of which the reporting person holds 100% membership interest.


Filed on 2009-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021076.txt Sec File: edgar/data/901430/0001225208-09-021076-index.htm

2009-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $8.49 remaining shares owned 4337749

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.68 to $8.43. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f2 shares held by a limited liability company of which the reporting person holds 100% membership interest.


Filed on 2009-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021076.txt Sec File: edgar/data/901430/0001225208-09-021076-index.htm

2009-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-26 exercise price 0 has valueitem expiration due date 2010-10-26 underlying security shares 50000 underlying security title Common Stock

f6 under the variable prepaid forward sale contract reported on this form, the reporting person will deliver to an unaffiliated commercial bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 26, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.5162 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares but not less than 35,700 shares. in exchange, the bank is obligated to pay $363,428.84 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021076.txt Sec File: edgar/data/901430/0001225208-09-021076-index.htm

2009-10-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-10-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021021.txt Sec File: edgar/data/901430/0001225208-09-021021-index.htm

2009-10-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-10-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021021.txt Sec File: edgar/data/901430/0001225208-09-021021-index.htm

2009-10-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 18234781

Common Stock Boston Scientific Corp Bsx


Filed on 2009-10-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021021.txt Sec File: edgar/data/901430/0001225208-09-021021-index.htm

2009-10-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-10-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021021.txt Sec File: edgar/data/901430/0001225208-09-021021-index.htm

2009-10-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $8.68 remaining shares owned 4487749

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.73 to $8.66. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f2 shares held by a limited liability company of which the reporting person holds 100% membership interest.


Filed on 2009-10-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021021.txt Sec File: edgar/data/901430/0001225208-09-021021-index.htm

2009-10-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 50000 shares at $8.5521 remaining shares owned 4437749

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.61 to $8.50. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
f2 shares held by a limited liability company of which the reporting person holds 100% membership interest.


Filed on 2009-10-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-021021.txt Sec File: edgar/data/901430/0001225208-09-021021-index.htm

2009-10-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-22 exercise price 0 has valueitem expiration due date 2010-10-22 underlying security shares 50000 underlying security title Common Stock

f6 under the variable prepaid forward sale contract reported on this form, the reporting person will deliver to an unaffiliated commercial bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 22, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.6435 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $346,604.35 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020864.txt Sec File: edgar/data/901430/0001225208-09-020864-index.htm

2009-10-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-21 exercise price 0 has valueitem expiration due date 2010-10-21 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 21, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.3147 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $332,588.00 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020789.txt Sec File: edgar/data/901430/0001225208-09-020789-index.htm

2009-10-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-20 exercise price 0 has valueitem expiration due date 2010-10-20 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 20, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.4978 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $338,127.46 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020759.txt Sec File: edgar/data/901430/0001225208-09-020759-index.htm

2009-10-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-19 exercise price 0 has valueitem expiration due date 2010-10-19 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 19, 2010. if the market price per share at maturity is equal to or less than the floor price of $10.2228 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $412,132.18 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020703.txt Sec File: edgar/data/901430/0001225208-09-020703-index.htm

2009-10-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-18 exercise price 0 has valueitem expiration due date 2010-10-18 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 18, 2010. if the market price per share at maturity is equal to or less than the floor price of $9.9804 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $401,711.10 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020667.txt Sec File: edgar/data/901430/0001225208-09-020667-index.htm

2009-10-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-15 exercise price 0 has valueitem expiration due date 2010-10-15 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 15, 2010. if the market price per share at maturity is equal to or less than the floor price of $10.0906 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $405,894.39 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020600.txt Sec File: edgar/data/901430/0001225208-09-020600-index.htm

2009-10-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-14 exercise price 0 has valueitem expiration due date 2010-10-14 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 14, 2010. if the market price per share at maturity is equal to or less than the floor price of $10.0294 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $403,031.44 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020559.txt Sec File: edgar/data/901430/0001225208-09-020559-index.htm

2009-10-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-13 exercise price 0 has valueitem expiration due date 2010-10-13 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 13, 2010. if the market price per share at maturity is equal to or less than the floor price of $9.9403 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $399,053.34 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020509.txt Sec File: edgar/data/901430/0001225208-09-020509-index.htm

2009-10-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 100000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-12 exercise price 0 has valueitem expiration due date 2010-10-12 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 12, 2010. if the market price per share at maturity is equal to or less than the floor price of $10.0538 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $403,911.42 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020511.txt Sec File: edgar/data/901430/0001225208-09-020511-index.htm

2009-10-09 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-12 exercise price 0 has valueitem expiration due date 2010-10-12 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 12, 2010. if the market price per share at maturity is equal to or less than the floor price of $10.2840 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $413,673.90 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020473.txt Sec File: edgar/data/901430/0001225208-09-020473-index.htm

2009-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-08 exercise price 0 has valueitem expiration due date 2010-10-08 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 8, 2010. if the market price per share at maturity is equal to or less than the floor price of $10.3038 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $413,697.57 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-09 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020436.txt Sec File: edgar/data/901430/0001225208-09-020436-index.htm

2009-10-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-07 exercise price 0 has valueitem expiration due date 2010-10-07 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 7, 2010. if the market price per share at maturity is equal to or less than the floor price of $10.1201 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $405,816.01 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020421.txt Sec File: edgar/data/901430/0001225208-09-020421-index.htm

2009-10-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 50000 shares at $0 remaining shares owned 50000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-10-06 exercise price 0 has valueitem expiration due date 2010-10-06 underlying security shares 50000 underlying security title Common Stock

f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 50,000 shares of the issuer's common stock depending on market prices at maturity on october 6, 2010. if the market price per share at maturity is equal to or less than the floor price of $9.9086 per share, the reporting person will deliver 50,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $397,136.69 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f2 the reporting person pledged 50,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-10-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-020244.txt Sec File: edgar/data/901430/0001225208-09-020244-index.htm

2009-10-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-10-03 exercise price 0 has valueitem expiration due date 2011-10-03 underlying security shares 60000 underlying security title Common Stock

f2 under the contract represented on this form, the bank is obligated to pay $482,539.87 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $12.04, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $12.04, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $10.0341, the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $10.0341, the reporting person will deliver a fewer number of shares.
f3 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on october 3, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-10-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-019807.txt Sec File: edgar/data/901430/0001225208-09-019807-index.htm

2009-09-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-29 exercise price 0 has valueitem expiration due date 2011-09-29 underlying security shares 60000 underlying security title Common Stock

f2 under the contract represented on this form, the bank is obligated to pay $516,662.77 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $12.84, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $12.84, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $10.7036, the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $10.7036, the reporting person will deliver a fewer number of shares.
f3 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 29, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-28 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-019408.txt Sec File: edgar/data/901430/0001225208-09-019408-index.htm

2009-09-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-26 exercise price 0 has valueitem expiration due date 2011-09-26 underlying security shares 60000 underlying security title Common Stock

f2 under the contract represented on this form, the bank is obligated to pay $514,632.34 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $12.78, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $12.78, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $10.6483, the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $10.6483, the reporting person will deliver a fewer number of shares.
f3 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 26, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-019265.txt Sec File: edgar/data/901430/0001225208-09-019265-index.htm

2009-09-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-22 exercise price 0 has valueitem expiration due date 2011-09-22 underlying security shares 60000 underlying security title Common Stock

f2 under the contract represented on this form, the bank is obligated to pay $530,765.72 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.16, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.16, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $10.9685, the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $10.9685, the reporting person will deliver a fewer number of shares.
f3 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 22, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-019144.txt Sec File: edgar/data/901430/0001225208-09-019144-index.htm

2009-09-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-19 exercise price 0 has valueitem expiration due date 2011-09-19 underlying security shares 60000 underlying security title Common Stock

f2 under the contract represented on this form, the bank is obligated to pay $532,087.20 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.24, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.24, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $11.03, the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $11.03, the reporting person will deliver a fewer number of shares.
f3 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 19, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-019144.txt Sec File: edgar/data/901430/0001225208-09-019144-index.htm

2009-09-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 120000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-19 exercise price 0 has valueitem expiration due date 2011-09-19 underlying security shares 60000 underlying security title Common Stock

f4 under the contract represented on this form, the bank is obligated to pay $528,141.17 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.14, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.14, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $10.9482, the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $10.9482, the reporting person will deliver a fewer number of shares.
f3 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 19, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-14 by Abele John E SEC CIK 901430 Form 4/a

Accession 0001225208-09-018862.txt Sec File: edgar/data/901430/0001225208-09-018862-index.htm

2009-09-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-02 exercise price 0 has valueitem expiration due date 2011-09-02 underlying security shares 60000 underlying security title Common Stock

f1 this form is being amended to add footnote #4. the original transactions are being reported again in order to gain access to the sec filing system.
f3 under the contract represented on this form, the bank is obligated to pay $530,727.63 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.26, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.26 the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $11.0513 the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $11.0513, the reporting person will deliver a fewer number of shares.
f4 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f2 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 2, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-018859.txt Sec File: edgar/data/901430/0001225208-09-018859-index.htm

2009-09-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-12 exercise price 0 has valueitem expiration due date 2011-09-12 underlying security shares 60000 underlying security title Common Stock

f2 under the contract represented on this form, the bank is obligated to pay $559,665.54 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.93 the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.93, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $11.6118, the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $11.6118, the reporting person will deliver a fewer number of shares.
f3 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 12, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-14 by Abele John E SEC CIK 901430 Form 4/a

Accession 0001225208-09-018864.txt Sec File: edgar/data/901430/0001225208-09-018864-index.htm

2009-09-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-08 exercise price 0 has valueitem expiration due date 2011-09-08 underlying security shares 60000 underlying security title Common Stock

f1 this form is being amended to add footnote #4. the original transactions are being reported again in order to gain access to the sec filing system.
f3 under the contract represented on this form, the bank is obligated to pay $541,974.30 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.52, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.52, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $11.27, the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $11.27, the reporting person will deliver a fewer number of shares.
f4 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f2 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 8, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-14 by Abele John E SEC CIK 901430 Form 4/a

Accession 0001225208-09-018862.txt Sec File: edgar/data/901430/0001225208-09-018862-index.htm

2009-09-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-06 exercise price 0 has valueitem expiration due date 2011-09-06 underlying security shares 60000 underlying security title Common Stock

f1 this form is being amended to add footnote #4. the original transactions are being reported again in order to gain access to the sec filing system.
f6 under the contract represented on this form, the bank is obligated to pay $539,588.84 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.47, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.47, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $11.2274 the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $11.2274, the reporting person will deliver a fewer number of shares.
f4 the reporting person pledged 60,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f5 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 6, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-018697.txt Sec File: edgar/data/901430/0001225208-09-018697-index.htm

2009-09-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-08 exercise price 0 has valueitem expiration due date 2011-09-08 underlying security shares 60000 underlying security title Common Stock

f2 under the contract represented on this form, the bank is obligated to pay $541,974.30 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.52, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.52, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $11.27, the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $11.27, the reporting person will deliver a fewer number of shares.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 8, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-018555.txt Sec File: edgar/data/901430/0001225208-09-018555-index.htm

2009-09-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-06 exercise price 0 has valueitem expiration due date 2011-09-06 underlying security shares 60000 underlying security title Common Stock

f4 under the contract represented on this form, the bank is obligated to pay $539,588.84 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.47, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.47, the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $11.2274 the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $11.2274, the reporting person will deliver a fewer number of shares.
f3 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 6, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-09-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-018555.txt Sec File: edgar/data/901430/0001225208-09-018555-index.htm

2009-09-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 60000 shares at $0 remaining shares owned 60000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2011-09-02 exercise price 0 has valueitem expiration due date 2011-09-02 underlying security shares 60000 underlying security title Common Stock

f2 under the contract represented on this form, the bank is obligated to pay $530,727.63 to the reporting person two business days after the date of the contract. in addition, if the market price per share on the first anniversary of the contract date is equal to or greater than approximately $13.26, the bank is obligated to pay an additional amount, determined by the bank based on the stock price at the time, to the reporting person three business days after the anniversary. if the market price per share on the first anniversary of the contract date is less than approximately $13.26 the contract will then be terminated and the reporting person will deliver shares to the bank. if the market price per share upon an early termination is equal to or less than $11.0513 the reporting person will deliver 60,000 shares to the bank. if the market price per share upon an early termination is greater than $11.0513, the reporting person will deliver a fewer number of shares.
f1 on august 26, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 60,000 shares of the issuer's common stock depending on market prices at maturity on september 2, 2011. if the market price per share at maturity is equal to or less than the floor price, the reporting person will deliver 60,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. the floor price will be determined by the bank based on the stock price on the first anniversary of the contract date. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-05-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012741.txt Sec File: edgar/data/901430/0001225208-09-012741-index.htm

2009-05-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012741.txt Sec File: edgar/data/901430/0001225208-09-012741-index.htm

2009-05-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012741.txt Sec File: edgar/data/901430/0001225208-09-012741-index.htm

2009-05-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.808 remaining shares owned 22922530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.93 to $8.72. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012741.txt Sec File: edgar/data/901430/0001225208-09-012741-index.htm

2009-05-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.645 remaining shares owned 22822530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.75 to $8.56. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012571.txt Sec File: edgar/data/901430/0001225208-09-012571-index.htm

2009-05-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012571.txt Sec File: edgar/data/901430/0001225208-09-012571-index.htm

2009-05-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012571.txt Sec File: edgar/data/901430/0001225208-09-012571-index.htm

2009-05-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.801 remaining shares owned 23122530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.95 to $8.66. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012571.txt Sec File: edgar/data/901430/0001225208-09-012571-index.htm

2009-05-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.983 remaining shares owned 23022530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.05 to $8.78. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012327.txt Sec File: edgar/data/901430/0001225208-09-012327-index.htm

2009-05-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012327.txt Sec File: edgar/data/901430/0001225208-09-012327-index.htm

2009-05-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $9.241 remaining shares owned 23222530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.34 to $9.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012327.txt Sec File: edgar/data/901430/0001225208-09-012327-index.htm

2009-05-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $9.145 remaining shares owned 23322530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.28 to $9.09. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012327.txt Sec File: edgar/data/901430/0001225208-09-012327-index.htm

2009-05-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-11 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012106.txt Sec File: edgar/data/901430/0001225208-09-012106-index.htm

2009-05-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $9.234 remaining shares owned 23422530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.33 to $9.20. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-11 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012106.txt Sec File: edgar/data/901430/0001225208-09-012106-index.htm

2009-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.845 remaining shares owned 23522530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.93 to $8.80. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-11 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012106.txt Sec File: edgar/data/901430/0001225208-09-012106-index.htm

2009-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-11 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-012106.txt Sec File: edgar/data/901430/0001225208-09-012106-index.htm

2009-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-011854.txt Sec File: edgar/data/901430/0001225208-09-011854-index.htm

2009-05-05 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.503 remaining shares owned 23722530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.56 to $8.45. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-011854.txt Sec File: edgar/data/901430/0001225208-09-011854-index.htm

2009-05-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.481 remaining shares owned 23622530

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.61 to $8.39. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-05-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-011854.txt Sec File: edgar/data/901430/0001225208-09-011854-index.htm

2009-05-05 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-011854.txt Sec File: edgar/data/901430/0001225208-09-011854-index.htm

2009-05-05 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-011843.txt Sec File: edgar/data/901430/0001225208-09-011843-index.htm

2009-05-05 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 14501 shares at $0 remaining shares owned 23822530

Common Stock Boston Scientific Corp Bsx Transaction code: A Grant, award, or other acquisition

f1 annual grant of restricted stock vesting upon the expiration of non-employee director's current term of office. reflects a value of $125,000 divided by the closing price of common stock on the date of grant.


Filed on 2009-05-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-011843.txt Sec File: edgar/data/901430/0001225208-09-011843-index.htm

2009-05-05 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f3 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-05-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-011843.txt Sec File: edgar/data/901430/0001225208-09-011843-index.htm

2009-05-05 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f2 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010629.txt Sec File: edgar/data/901430/0001225208-09-010629-index.htm

2009-04-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.644 remaining shares owned 23808029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.79 to $8.50. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010629.txt Sec File: edgar/data/901430/0001225208-09-010629-index.htm

2009-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 100000 shares at $0 remaining shares owned 100000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-04-21 exercise price 0 has valueitem expiration due date 2010-04-21 underlying security shares 100000 underlying security title Common Stock

f6 on february 27, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity on april 21, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.53 per share, the reporting person will deliver 100,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $635,296.12 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 100,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010629.txt Sec File: edgar/data/901430/0001225208-09-010629-index.htm

2009-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010629.txt Sec File: edgar/data/901430/0001225208-09-010629-index.htm

2009-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010629.txt Sec File: edgar/data/901430/0001225208-09-010629-index.htm

2009-04-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.464 remaining shares owned 23958029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.66 to $8.30. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010508.txt Sec File: edgar/data/901430/0001225208-09-010508-index.htm

2009-04-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.981 remaining shares owned 24258029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.10 to $8.91. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010508.txt Sec File: edgar/data/901430/0001225208-09-010508-index.htm

2009-04-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010508.txt Sec File: edgar/data/901430/0001225208-09-010508-index.htm

2009-04-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.755 remaining shares owned 24108029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.85 to $8.65. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010508.txt Sec File: edgar/data/901430/0001225208-09-010508-index.htm

2009-04-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010444.txt Sec File: edgar/data/901430/0001225208-09-010444-index.htm

2009-04-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010444.txt Sec File: edgar/data/901430/0001225208-09-010444-index.htm

2009-04-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010444.txt Sec File: edgar/data/901430/0001225208-09-010444-index.htm

2009-04-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $9.008 remaining shares owned 24558029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.04 to $8.96. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010444.txt Sec File: edgar/data/901430/0001225208-09-010444-index.htm

2009-04-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.996 remaining shares owned 24408029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.04 to $8.90. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010318.txt Sec File: edgar/data/901430/0001225208-09-010318-index.htm

2009-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010318.txt Sec File: edgar/data/901430/0001225208-09-010318-index.htm

2009-04-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.939 remaining shares owned 24708029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.02 to $8.87. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010318.txt Sec File: edgar/data/901430/0001225208-09-010318-index.htm

2009-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.852 remaining shares owned 24858029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.96 to $8.74. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010318.txt Sec File: edgar/data/901430/0001225208-09-010318-index.htm

2009-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010318.txt Sec File: edgar/data/901430/0001225208-09-010318-index.htm

2009-04-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 100000 shares at $0 remaining shares owned 100000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-04-13 exercise price 0 has valueitem expiration due date 2010-04-13 underlying security shares 100000 underlying security title Common Stock

f6 on february 27, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity on april 13, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.77 per share, the reporting person will deliver 100,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $645,995.24 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 100,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-04-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010228.txt Sec File: edgar/data/901430/0001225208-09-010228-index.htm

2009-04-09 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010228.txt Sec File: edgar/data/901430/0001225208-09-010228-index.htm

2009-04-09 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010228.txt Sec File: edgar/data/901430/0001225208-09-010228-index.htm

2009-04-09 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.88 remaining shares owned 25008029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.91 to $8.84. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-09 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010160.txt Sec File: edgar/data/901430/0001225208-09-010160-index.htm

2009-04-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.483 remaining shares owned 25158029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.59 to $8.39. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-09 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010160.txt Sec File: edgar/data/901430/0001225208-09-010160-index.htm

2009-04-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-09 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010160.txt Sec File: edgar/data/901430/0001225208-09-010160-index.htm

2009-04-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-09 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010160.txt Sec File: edgar/data/901430/0001225208-09-010160-index.htm

2009-04-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.427 remaining shares owned 25308029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.52 to $8.33. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010039.txt Sec File: edgar/data/901430/0001225208-09-010039-index.htm

2009-04-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010039.txt Sec File: edgar/data/901430/0001225208-09-010039-index.htm

2009-04-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010039.txt Sec File: edgar/data/901430/0001225208-09-010039-index.htm

2009-04-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.368 remaining shares owned 25608029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.41 to $8.30. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010039.txt Sec File: edgar/data/901430/0001225208-09-010039-index.htm

2009-04-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.431 remaining shares owned 25458029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.50 to $8.40. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-07 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-010039.txt Sec File: edgar/data/901430/0001225208-09-010039-index.htm

2009-04-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 100000 shares at $0 remaining shares owned 100000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-04-06 exercise price 0 has valueitem expiration due date 2010-04-06 underlying security shares 100000 underlying security title Common Stock

f6 on february 27, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity on april 6, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.40 per share, the reporting person will deliver 100,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $616,863.40 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 100,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-04-03 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-009863.txt Sec File: edgar/data/901430/0001225208-09-009863-index.htm

2009-04-01 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-03 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-009863.txt Sec File: edgar/data/901430/0001225208-09-009863-index.htm

2009-04-01 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-03 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-009863.txt Sec File: edgar/data/901430/0001225208-09-009863-index.htm

2009-04-01 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.97 remaining shares owned 25908029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.15 to $7.82. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-03 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-009863.txt Sec File: edgar/data/901430/0001225208-09-009863-index.htm

2009-04-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.487 remaining shares owned 25758029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.59 to $8.41. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-009248.txt Sec File: edgar/data/901430/0001225208-09-009248-index.htm

2009-03-31 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.033 remaining shares owned 26058029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.14 to $7.93. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-009248.txt Sec File: edgar/data/901430/0001225208-09-009248-index.htm

2009-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-009248.txt Sec File: edgar/data/901430/0001225208-09-009248-index.htm

2009-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-009248.txt Sec File: edgar/data/901430/0001225208-09-009248-index.htm

2009-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 100000 shares at $0 remaining shares owned 100000

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-03-30 exercise price 0 has valueitem expiration due date 2010-03-30 underlying security shares 100000 underlying security title Common Stock

f6 on february 27, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity on march 30, 2010. if the market price per share at maturity is equal to or less than the floor price of $7.92 per share, the reporting person will deliver 100,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $577,836.79 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 100,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-04-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-009248.txt Sec File: edgar/data/901430/0001225208-09-009248-index.htm

2009-03-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.965 remaining shares owned 26208029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.10 to $7.90. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-008714.txt Sec File: edgar/data/901430/0001225208-09-008714-index.htm

2009-03-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-008714.txt Sec File: edgar/data/901430/0001225208-09-008714-index.htm

2009-03-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.224 remaining shares owned 26358029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.42 to $8.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-008714.txt Sec File: edgar/data/901430/0001225208-09-008714-index.htm

2009-03-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.432 remaining shares owned 26508029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.53 to $8.30. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-008714.txt Sec File: edgar/data/901430/0001225208-09-008714-index.htm

2009-03-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007729.txt Sec File: edgar/data/901430/0001225208-09-007729-index.htm

2009-03-25 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.076 remaining shares owned 26658029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.35 to $7.76. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007729.txt Sec File: edgar/data/901430/0001225208-09-007729-index.htm

2009-03-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007729.txt Sec File: edgar/data/901430/0001225208-09-007729-index.htm

2009-03-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007729.txt Sec File: edgar/data/901430/0001225208-09-007729-index.htm

2009-03-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.242 remaining shares owned 26808029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.47 to $8.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007617.txt Sec File: edgar/data/901430/0001225208-09-007617-index.htm

2009-03-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007617.txt Sec File: edgar/data/901430/0001225208-09-007617-index.htm

2009-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 100000 shares at $0 remaining shares owned 100000

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-03-23 exercise price 0 has valueitem expiration due date 2010-03-23 underlying security shares 100000 underlying security title Common Stock

f6 on february 27, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity on march 23, 2010. if the market price per share at maturity is equal to or less than the floor price of $7.91 per share, the reporting person will deliver 100,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $594,173.48 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 100,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007617.txt Sec File: edgar/data/901430/0001225208-09-007617-index.htm

2009-03-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.857 remaining shares owned 26958029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.01 to $7.62. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007617.txt Sec File: edgar/data/901430/0001225208-09-007617-index.htm

2009-03-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.601 remaining shares owned 27108029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.91 to $7.50. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007617.txt Sec File: edgar/data/901430/0001225208-09-007617-index.htm

2009-03-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007535.txt Sec File: edgar/data/901430/0001225208-09-007535-index.htm

2009-03-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.813 remaining shares owned 27258029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.95 to $7.70. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007535.txt Sec File: edgar/data/901430/0001225208-09-007535-index.htm

2009-03-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007535.txt Sec File: edgar/data/901430/0001225208-09-007535-index.htm

2009-03-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.874 remaining shares owned 27408029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.22 to $7.65. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007535.txt Sec File: edgar/data/901430/0001225208-09-007535-index.htm

2009-03-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007370.txt Sec File: edgar/data/901430/0001225208-09-007370-index.htm

2009-03-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.508 remaining shares owned 27558029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.55 to $7.43. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007370.txt Sec File: edgar/data/901430/0001225208-09-007370-index.htm

2009-03-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.752 remaining shares owned 27708029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.80 to $7.70. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007370.txt Sec File: edgar/data/901430/0001225208-09-007370-index.htm

2009-03-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 100000 shares at $0 remaining shares owned 100000

Forward Sale Contract Obligation To Sell Boston Scientific Corp Bsx exercise date 2010-03-16 exercise price 0 has valueitem expiration due date 2010-03-16 underlying security shares 100000 underlying security title Common Stock

f6 on february 27, 2009, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 100,000 shares of the issuer's common stock depending on market prices at maturity on march 16, 2010. if the market price per share at maturity is equal to or less than the floor price of $7.73 per share, the reporting person will deliver 100,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $568,335.21 to the reporting person two business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
f7 the reporting person pledged 100,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.


Filed on 2009-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007370.txt Sec File: edgar/data/901430/0001225208-09-007370-index.htm

2009-03-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-18 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007370.txt Sec File: edgar/data/901430/0001225208-09-007370-index.htm

2009-03-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007243.txt Sec File: edgar/data/901430/0001225208-09-007243-index.htm

2009-03-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007243.txt Sec File: edgar/data/901430/0001225208-09-007243-index.htm

2009-03-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.412 remaining shares owned 27858029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.53 to $7.25. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007243.txt Sec File: edgar/data/901430/0001225208-09-007243-index.htm

2009-03-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $7.09 remaining shares owned 28008029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.17 to $7.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-007243.txt Sec File: edgar/data/901430/0001225208-09-007243-index.htm

2009-03-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006996.txt Sec File: edgar/data/901430/0001225208-09-006996-index.htm

2009-03-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006996.txt Sec File: edgar/data/901430/0001225208-09-006996-index.htm

2009-03-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $6.879 remaining shares owned 28158029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.95 to $6.75. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006996.txt Sec File: edgar/data/901430/0001225208-09-006996-index.htm

2009-03-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $6.647 remaining shares owned 28308029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.76 to $6.42. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006996.txt Sec File: edgar/data/901430/0001225208-09-006996-index.htm

2009-03-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006738.txt Sec File: edgar/data/901430/0001225208-09-006738-index.htm

2009-03-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006738.txt Sec File: edgar/data/901430/0001225208-09-006738-index.htm

2009-03-09 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $6.222 remaining shares owned 28458029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.43 to $6.10. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006738.txt Sec File: edgar/data/901430/0001225208-09-006738-index.htm

2009-03-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $6.31 remaining shares owned 28608029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.56 to $6.18. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006738.txt Sec File: edgar/data/901430/0001225208-09-006738-index.htm

2009-03-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006513.txt Sec File: edgar/data/901430/0001225208-09-006513-index.htm

2009-03-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006513.txt Sec File: edgar/data/901430/0001225208-09-006513-index.htm

2009-03-05 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $6.639 remaining shares owned 28758029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.95 to $6.46. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006513.txt Sec File: edgar/data/901430/0001225208-09-006513-index.htm

2009-03-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $6.814 remaining shares owned 28908029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.90 to $6.75. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006513.txt Sec File: edgar/data/901430/0001225208-09-006513-index.htm

2009-03-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006085.txt Sec File: edgar/data/901430/0001225208-09-006085-index.htm

2009-03-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006085.txt Sec File: edgar/data/901430/0001225208-09-006085-index.htm

2009-03-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-03-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006085.txt Sec File: edgar/data/901430/0001225208-09-006085-index.htm

2009-03-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $6.752 remaining shares owned 29208029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.90 to $6.67. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-03-04 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-006085.txt Sec File: edgar/data/901430/0001225208-09-006085-index.htm

2009-03-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $6.78 remaining shares owned 29058029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 27, 2009.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.91 to $6.65. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-005066.txt Sec File: edgar/data/901430/0001225208-09-005066-index.htm

2009-02-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f2 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-005066.txt Sec File: edgar/data/901430/0001225208-09-005066-index.htm

2009-02-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f3 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-005066.txt Sec File: edgar/data/901430/0001225208-09-005066-index.htm

2009-02-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 200000 shares at $8.23 remaining shares owned 29358029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.25 to $8.20. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004835.txt Sec File: edgar/data/901430/0001225208-09-004835-index.htm

2009-02-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.255 remaining shares owned 29558029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.27 to $8.25. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004835.txt Sec File: edgar/data/901430/0001225208-09-004835-index.htm

2009-02-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f3 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004835.txt Sec File: edgar/data/901430/0001225208-09-004835-index.htm

2009-02-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f2 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004510.txt Sec File: edgar/data/901430/0001225208-09-004510-index.htm

2009-02-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004510.txt Sec File: edgar/data/901430/0001225208-09-004510-index.htm

2009-02-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004510.txt Sec File: edgar/data/901430/0001225208-09-004510-index.htm

2009-02-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 225000 shares at $8.659 remaining shares owned 29833029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.76 to $8.47. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004510.txt Sec File: edgar/data/901430/0001225208-09-004510-index.htm

2009-02-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 175000 shares at $8.358 remaining shares owned 29658029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.57 to $8.04. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004465.txt Sec File: edgar/data/901430/0001225208-09-004465-index.htm

2009-02-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f2 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004465.txt Sec File: edgar/data/901430/0001225208-09-004465-index.htm

2009-02-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f3 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-004465.txt Sec File: edgar/data/901430/0001225208-09-004465-index.htm

2009-02-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.452 remaining shares owned 30058029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.65 to $8.39. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-003853.txt Sec File: edgar/data/901430/0001225208-09-003853-index.htm

2009-02-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 175000 shares at $8.913 remaining shares owned 30208029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.98 to $8.85. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-003853.txt Sec File: edgar/data/901430/0001225208-09-003853-index.htm

2009-02-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f3 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-003853.txt Sec File: edgar/data/901430/0001225208-09-003853-index.htm

2009-02-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f2 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-003655.txt Sec File: edgar/data/901430/0001225208-09-003655-index.htm

2009-02-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-003655.txt Sec File: edgar/data/901430/0001225208-09-003655-index.htm

2009-02-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-003655.txt Sec File: edgar/data/901430/0001225208-09-003655-index.htm

2009-02-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.732 remaining shares owned 30533029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.87 to $8.61. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-13 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-003655.txt Sec File: edgar/data/901430/0001225208-09-003655-index.htm

2009-02-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 150000 shares at $8.751 remaining shares owned 30383029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.76 to $8.75. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002473.txt Sec File: edgar/data/901430/0001225208-09-002473-index.htm

2009-01-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.892 remaining shares owned 30783029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.62 to $8.55. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002473.txt Sec File: edgar/data/901430/0001225208-09-002473-index.htm

2009-01-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-29 exercise price 0 has valueitem expiration due date 2010-01-29 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on january 29, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.96 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $891,693.33 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002473.txt Sec File: edgar/data/901430/0001225208-09-002473-index.htm

2009-01-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002473.txt Sec File: edgar/data/901430/0001225208-09-002473-index.htm

2009-01-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.925 remaining shares owned 30683029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.18 to $8.80. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-02-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002473.txt Sec File: edgar/data/901430/0001225208-09-002473-index.htm

2009-01-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002191.txt Sec File: edgar/data/901430/0001225208-09-002191-index.htm

2009-01-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.66 remaining shares owned 30883029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.79 to $8.52. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002191.txt Sec File: edgar/data/901430/0001225208-09-002191-index.htm

2009-01-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-27 exercise price 0 has valueitem expiration due date 2010-01-27 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on january 27, 2010. if the market price per share at maturity is equal to or less than the floor price of $8.43 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $872,559.05 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002191.txt Sec File: edgar/data/901430/0001225208-09-002191-index.htm

2009-01-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $8.45 remaining shares owned 30983029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.66 to $8.04. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002191.txt Sec File: edgar/data/901430/0001225208-09-002191-index.htm

2009-01-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-29 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002191.txt Sec File: edgar/data/901430/0001225208-09-002191-index.htm

2009-01-27 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002047.txt Sec File: edgar/data/901430/0001225208-09-002047-index.htm

2009-01-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002047.txt Sec File: edgar/data/901430/0001225208-09-002047-index.htm

2009-01-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002047.txt Sec File: edgar/data/901430/0001225208-09-002047-index.htm

2009-01-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.651 remaining shares owned 31183029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.80 to $7.54. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002047.txt Sec File: edgar/data/901430/0001225208-09-002047-index.htm

2009-01-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.973 remaining shares owned 31083029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.11 to $7.71. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-27 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-002047.txt Sec File: edgar/data/901430/0001225208-09-002047-index.htm

2009-01-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-22 exercise price 0 has valueitem expiration due date 2010-01-22 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on january 22, 2010. if the market price per share at maturity is equal to or less than the floor price of $7.65 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $759,124.47 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001937.txt Sec File: edgar/data/901430/0001225208-09-001937-index.htm

2009-01-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001937.txt Sec File: edgar/data/901430/0001225208-09-001937-index.htm

2009-01-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.843 remaining shares owned 31283029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.97 to $7.70. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001937.txt Sec File: edgar/data/901430/0001225208-09-001937-index.htm

2009-01-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-21 exercise price 0 has valueitem expiration due date 2010-01-21 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on january 21, 2010. if the market price per share at maturity is equal to or less than the floor price of $7.65 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $790,656.96 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001937.txt Sec File: edgar/data/901430/0001225208-09-001937-index.htm

2009-01-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001937.txt Sec File: edgar/data/901430/0001225208-09-001937-index.htm

2009-01-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.705 remaining shares owned 31383029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.94 to $7.53. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001688.txt Sec File: edgar/data/901430/0001225208-09-001688-index.htm

2009-01-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.64 remaining shares owned 31483029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.94 to $7.44. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001688.txt Sec File: edgar/data/901430/0001225208-09-001688-index.htm

2009-01-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.78 remaining shares owned 31583029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.94 to $7.66. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001688.txt Sec File: edgar/data/901430/0001225208-09-001688-index.htm

2009-01-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001688.txt Sec File: edgar/data/901430/0001225208-09-001688-index.htm

2009-01-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001546.txt Sec File: edgar/data/901430/0001225208-09-001546-index.htm

2009-01-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-15 exercise price 0 has valueitem expiration due date 2010-01-15 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on january 15, 2010. if the market price per share at maturity is equal to or less than the floor price of $7.32 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $726,946.53 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001546.txt Sec File: edgar/data/901430/0001225208-09-001546-index.htm

2009-01-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.403 remaining shares owned 31683029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.65 to $7.17. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001546.txt Sec File: edgar/data/901430/0001225208-09-001546-index.htm

2009-01-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.279 remaining shares owned 31783029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.40 to $7.12. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001546.txt Sec File: edgar/data/901430/0001225208-09-001546-index.htm

2009-01-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001546.txt Sec File: edgar/data/901430/0001225208-09-001546-index.htm

2009-01-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001433.txt Sec File: edgar/data/901430/0001225208-09-001433-index.htm

2009-01-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-13 exercise price 0 has valueitem expiration due date 2010-01-13 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on january 13, 2010. if the market price per share at maturity is equal to or less than the floor price of $7.41 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $769,121.78 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001433.txt Sec File: edgar/data/901430/0001225208-09-001433-index.htm

2009-01-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001433.txt Sec File: edgar/data/901430/0001225208-09-001433-index.htm

2009-01-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001433.txt Sec File: edgar/data/901430/0001225208-09-001433-index.htm

2009-01-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.441 remaining shares owned 31983029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.66 to $7.26. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-14 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001433.txt Sec File: edgar/data/901430/0001225208-09-001433-index.htm

2009-01-13 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.39 remaining shares owned 31883029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.56 to $7.20. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001329.txt Sec File: edgar/data/901430/0001225208-09-001329-index.htm

2009-01-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001329.txt Sec File: edgar/data/901430/0001225208-09-001329-index.htm

2009-01-09 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-08 exercise price 0 has valueitem expiration due date 2010-01-08 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on january 8, 2010. if the market price per share at maturity is equal to or less than the floor price of $7.71 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $764,627.92 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001329.txt Sec File: edgar/data/901430/0001225208-09-001329-index.htm

2009-01-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001329.txt Sec File: edgar/data/901430/0001225208-09-001329-index.htm

2009-01-09 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.715 remaining shares owned 32083029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.95 to $7.64. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-12 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001329.txt Sec File: edgar/data/901430/0001225208-09-001329-index.htm

2009-01-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.681 remaining shares owned 32183029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.81 to $7.53. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001139.txt Sec File: edgar/data/901430/0001225208-09-001139-index.htm

2009-01-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.894 remaining shares owned 32283029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.09 to $7.70. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001139.txt Sec File: edgar/data/901430/0001225208-09-001139-index.htm

2009-01-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001139.txt Sec File: edgar/data/901430/0001225208-09-001139-index.htm

2009-01-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2010-01-06 exercise price 0 has valueitem expiration due date 2010-01-06 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on january 6, 2010. if the market price per share at maturity is equal to or less than the floor price of $7.87 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $817,275.56 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001139.txt Sec File: edgar/data/901430/0001225208-09-001139-index.htm

2009-01-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-001139.txt Sec File: edgar/data/901430/0001225208-09-001139-index.htm

2009-01-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.926 remaining shares owned 32383029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.09 to $7.64. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-06 by Abele John E SEC CIK 901430 Form 4/a

Accession 0001225208-09-000731.txt Sec File: edgar/data/901430/0001225208-09-000731-index.htm

2008-12-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.513 remaining shares owned 33283029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 this form is being amended to correct the date originally inserted next to the signature line. the original filing indicates that the form was signed on 12/23/2009. the correct signature date is 12/23/2008. the original transactions are being reported in order to gain access to the sec filing system.
f2 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.89 to $7.32. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-06 by Abele John E SEC CIK 901430 Form 4/a

Accession 0001225208-09-000731.txt Sec File: edgar/data/901430/0001225208-09-000731-index.htm

2008-12-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.796 remaining shares owned 33383029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 this form is being amended to correct the date originally inserted next to the signature line. the original filing indicates that the form was signed on 12/23/2009. the correct signature date is 12/23/2008. the original transactions are being reported in order to gain access to the sec filing system.
f2 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.23 to $7.51. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-06 by Abele John E SEC CIK 901430 Form 4/a

Accession 0001225208-09-000731.txt Sec File: edgar/data/901430/0001225208-09-000731-index.htm

2008-12-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-18 exercise price 0 has valueitem expiration due date 2009-12-18 underlying security shares 119722 underlying security title Common Stock

f1 this form is being amended to correct the date originally inserted next to the signature line. the original filing indicates that the form was signed on 12/23/2009. the correct signature date is 12/23/2008. the original transactions are being reported in order to gain access to the sec filing system.
f6 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f5 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 18, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.71 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $757,171.49 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-06 by Abele John E SEC CIK 901430 Form 4/a

Accession 0001225208-09-000731.txt Sec File: edgar/data/901430/0001225208-09-000731-index.htm

2008-12-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-22 exercise price 0 has valueitem expiration due date 2009-12-22 underlying security shares 119722 underlying security title Common Stock

f1 this form is being amended to correct the date originally inserted next to the signature line. the original filing indicates that the form was signed on 12/23/2009. the correct signature date is 12/23/2008. the original transactions are being reported in order to gain access to the sec filing system.
f6 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f7 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 22, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.52 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $745,567.64 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-06 by Abele John E SEC CIK 901430 Form 4/a

Accession 0001225208-09-000751.txt Sec File: edgar/data/901430/0001225208-09-000751-index.htm

2008-12-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-10 exercise price 0 has valueitem expiration due date 2009-12-10 underlying security shares 119722 underlying security title Common Stock

f1 this form is being amended to correct the date originally inserted next to the signature line. the original filing indicates that the form was signed on 12/11/2009. the correct signature date is 12/11/2008. the original transaction is being reported in order to gain access to the sec filing system.
f3 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f2 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 10, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.28 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $709,978.48 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-000727.txt Sec File: edgar/data/901430/0001225208-09-000727-index.htm

2009-01-05 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.7 remaining shares owned 32483029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.92 to $7.52. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-000727.txt Sec File: edgar/data/901430/0001225208-09-000727-index.htm

2009-01-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.751 remaining shares owned 32583029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.94 to $7.51. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-000727.txt Sec File: edgar/data/901430/0001225208-09-000727-index.htm

2009-01-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-06 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-000727.txt Sec File: edgar/data/901430/0001225208-09-000727-index.htm

2009-01-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-000112.txt Sec File: edgar/data/901430/0001225208-09-000112-index.htm

2008-12-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2009-01-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-000112.txt Sec File: edgar/data/901430/0001225208-09-000112-index.htm

2008-12-31 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.597 remaining shares owned 32683029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.80 to $7.41. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-000112.txt Sec File: edgar/data/901430/0001225208-09-000112-index.htm

2008-12-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.341 remaining shares owned 32783029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.47 to $7.22. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2009-01-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-000112.txt Sec File: edgar/data/901430/0001225208-09-000112-index.htm

2008-12-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-30 exercise price 0 has valueitem expiration due date 2009-12-30 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 30, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.33 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $723,988.86 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2009-01-02 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-09-000112.txt Sec File: edgar/data/901430/0001225208-09-000112-index.htm

2008-12-30 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019962.txt Sec File: edgar/data/901430/0001225208-08-019962-index.htm

2008-12-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.332 remaining shares owned 32883029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.40 to $7.19. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019962.txt Sec File: edgar/data/901430/0001225208-08-019962-index.htm

2008-12-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019962.txt Sec File: edgar/data/901430/0001225208-08-019962-index.htm

2008-12-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019962.txt Sec File: edgar/data/901430/0001225208-08-019962-index.htm

2008-12-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.377 remaining shares owned 32983029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.50 to $7.33. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-30 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019962.txt Sec File: edgar/data/901430/0001225208-08-019962-index.htm

2008-12-29 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-29 exercise price 0 has valueitem expiration due date 2009-12-29 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 29, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.314 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $759,381.59 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2008-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019913.txt Sec File: edgar/data/901430/0001225208-08-019913-index.htm

2008-12-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.484 remaining shares owned 33183029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.71 to $7.36. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019913.txt Sec File: edgar/data/901430/0001225208-08-019913-index.htm

2008-12-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019913.txt Sec File: edgar/data/901430/0001225208-08-019913-index.htm

2008-12-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019913.txt Sec File: edgar/data/901430/0001225208-08-019913-index.htm

2008-12-23 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-23 exercise price 0 has valueitem expiration due date 2009-12-23 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 23, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.49 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $742,364.59 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2008-12-24 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019913.txt Sec File: edgar/data/901430/0001225208-08-019913-index.htm

2008-12-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.38 remaining shares owned 33083029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.49 to $7.33. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019884.txt Sec File: edgar/data/901430/0001225208-08-019884-index.htm

2008-12-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.513 remaining shares owned 33283029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.89 to $7.32. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019884.txt Sec File: edgar/data/901430/0001225208-08-019884-index.htm

2008-12-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019884.txt Sec File: edgar/data/901430/0001225208-08-019884-index.htm

2008-12-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019884.txt Sec File: edgar/data/901430/0001225208-08-019884-index.htm

2008-12-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.796 remaining shares owned 33383029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.23 to $7.51. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019884.txt Sec File: edgar/data/901430/0001225208-08-019884-index.htm

2008-12-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-18 exercise price 0 has valueitem expiration due date 2009-12-18 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 18, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.71 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $757,171.49 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2008-12-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019884.txt Sec File: edgar/data/901430/0001225208-08-019884-index.htm

2008-12-22 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-22 exercise price 0 has valueitem expiration due date 2009-12-22 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f8 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 22, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.52 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $745,567.64 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2008-12-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019660.txt Sec File: edgar/data/901430/0001225208-08-019660-index.htm

2008-12-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.707 remaining shares owned 33583029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.01 to $7.26. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019660.txt Sec File: edgar/data/901430/0001225208-08-019660-index.htm

2008-12-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019660.txt Sec File: edgar/data/901430/0001225208-08-019660-index.htm

2008-12-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019660.txt Sec File: edgar/data/901430/0001225208-08-019660-index.htm

2008-12-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-17 exercise price 0 has valueitem expiration due date 2009-12-17 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 17, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.55 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $741,168.83 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2008-12-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019660.txt Sec File: edgar/data/901430/0001225208-08-019660-index.htm

2008-12-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.932 remaining shares owned 33483029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.12 to $7.66. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019597.txt Sec File: edgar/data/901430/0001225208-08-019597-index.htm

2008-12-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.227 remaining shares owned 33683029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.44 to $7.13. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019597.txt Sec File: edgar/data/901430/0001225208-08-019597-index.htm

2008-12-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019597.txt Sec File: edgar/data/901430/0001225208-08-019597-index.htm

2008-12-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-17 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019597.txt Sec File: edgar/data/901430/0001225208-08-019597-index.htm

2008-12-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.25 remaining shares owned 33783029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.47 to $7.18. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019458.txt Sec File: edgar/data/901430/0001225208-08-019458-index.htm

2008-12-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-11 exercise price 0 has valueitem expiration due date 2009-12-11 underlying security shares 119722 underlying security title Common Stock

f7 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f6 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 11, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.12 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $694,074.87 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2008-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019458.txt Sec File: edgar/data/901430/0001225208-08-019458-index.htm

2008-12-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019458.txt Sec File: edgar/data/901430/0001225208-08-019458-index.htm

2008-12-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019458.txt Sec File: edgar/data/901430/0001225208-08-019458-index.htm

2008-12-11 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.431 remaining shares owned 33983029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.67 to $7.16. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-15 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019458.txt Sec File: edgar/data/901430/0001225208-08-019458-index.htm

2008-12-12 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100000 shares at $7.119 remaining shares owned 33883029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2008.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.23 to $6.98. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-11 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019281.txt Sec File: edgar/data/901430/0001225208-08-019281-index.htm

2008-12-10 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 119722 shares at $0 remaining shares owned 119722

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-10 exercise price 0 has valueitem expiration due date 2009-12-10 underlying security shares 119722 underlying security title Common Stock

f2 the reporting person pledged 119,722 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f1 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the issuer's common stock depending on market prices at maturity on december 10, 2009. if the market price per share at maturity is equal to or less than the floor price of $7.28 per share, the reporting person will deliver 119,722 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $709,978.48 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2008-12-05 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019073.txt Sec File: edgar/data/901430/0001225208-08-019073-index.htm

2008-12-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-05 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019073.txt Sec File: edgar/data/901430/0001225208-08-019073-index.htm

2008-12-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 27471 shares at $6.386 remaining shares owned 34083029

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan entered into by the reporting person on november 28, 2008. representatives of the reporting person have indicated that these sales were made to support margin arrangements with commercial lenders.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.60 to $6.20. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-05 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019073.txt Sec File: edgar/data/901430/0001225208-08-019073-index.htm

2008-12-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 500000 shares at $0 remaining shares owned 500000

Forward Sale Contract Boston Scientific Corp Bsx exercise date 2009-12-04 exercise price 0 has valueitem expiration due date 2009-12-04 underlying security shares 500000 underlying security title Common Stock

f6 the reporting person pledged 500,000 shares of the issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.
f5 on november 28, 2008, the reporting person entered into a rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. under the contract reported on this form, the reporting person will deliver to the bank up to 500,000 shares of the issuer's common stock depending on market prices at maturity on december 4, 2009. if the market price per share at maturity is equal to or less than the floor price of $6.637 per share, the reporting person will deliver 500,000 shares to the bank. if the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. in exchange, the bank is obligated to pay $2,850,720.35 to the reporting person three business days after the date of the contract. at the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.


Filed on 2008-12-05 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-019073.txt Sec File: edgar/data/901430/0001225208-08-019073-index.htm

2008-12-03 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-03 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018989.txt Sec File: edgar/data/901430/0001225208-08-018989-index.htm

2008-12-01 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-03 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018989.txt Sec File: edgar/data/901430/0001225208-08-018989-index.htm

2008-12-01 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-03 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018989.txt Sec File: edgar/data/901430/0001225208-08-018989-index.htm

2008-12-01 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 110227 shares at $5.963 remaining shares owned 34220727

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan entered into by the reporting person on november 28, 2008. representatives of the reporting person have indicated that these sales were made to support margin arrangements with commercial lenders.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.07 to $5.86. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-03 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018989.txt Sec File: edgar/data/901430/0001225208-08-018989-index.htm

2008-12-02 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 110227 shares at $6.055 remaining shares owned 34110500

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan entered into by the reporting person on november 28, 2008. representatives of the reporting person have indicated that these sales were made to support margin arrangements with commercial lenders.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.10 to $6.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018735.txt Sec File: edgar/data/901430/0001225208-08-018735-index.htm

2008-11-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f9 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-12-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018735.txt Sec File: edgar/data/901430/0001225208-08-018735-index.htm

2008-11-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 198000 shares at $6.078 remaining shares owned 35406954

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.11 to $5.98. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018735.txt Sec File: edgar/data/901430/0001225208-08-018735-index.htm

2008-11-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 250000 shares at $6.092 remaining shares owned 35156954

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.13 to $6.06. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018735.txt Sec File: edgar/data/901430/0001225208-08-018735-index.htm

2008-11-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 250000 shares at $6.181 remaining shares owned 34330954

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f7 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.30 to $6.06. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018735.txt Sec File: edgar/data/901430/0001225208-08-018735-index.htm

2008-11-28 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 76000 shares at $6.142 remaining shares owned 34580954

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f6 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.29 to $6.01. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018735.txt Sec File: edgar/data/901430/0001225208-08-018735-index.htm

2008-11-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 250000 shares at $6.068 remaining shares owned 34656954

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f5 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.11 to $6.00. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018735.txt Sec File: edgar/data/901430/0001225208-08-018735-index.htm

2008-11-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 250000 shares at $6.078 remaining shares owned 34906954

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f4 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.10 to $6.04. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-12-01 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018735.txt Sec File: edgar/data/901430/0001225208-08-018735-index.htm

2008-11-26 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f8 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-11-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018607.txt Sec File: edgar/data/901430/0001225208-08-018607-index.htm

2008-11-25 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 198000 shares at $6.152 remaining shares owned 35604954

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.37 to $5.94 the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-11-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018607.txt Sec File: edgar/data/901430/0001225208-08-018607-index.htm

2008-11-25 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-11-26 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018607.txt Sec File: edgar/data/901430/0001225208-08-018607-index.htm

2008-11-25 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-11-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018504.txt Sec File: edgar/data/901430/0001225208-08-018504-index.htm

2008-11-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-11-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018504.txt Sec File: edgar/data/901430/0001225208-08-018504-index.htm

2008-11-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 340000 shares at $5.746 remaining shares owned 35981454

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.17 to $5.58. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-11-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018504.txt Sec File: edgar/data/901430/0001225208-08-018504-index.htm

2008-11-24 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 178500 shares at $5.938 remaining shares owned 35802954

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.17 to $5.70. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-11-25 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018504.txt Sec File: edgar/data/901430/0001225208-08-018504-index.htm

2008-11-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-11-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018344.txt Sec File: edgar/data/901430/0001225208-08-018344-index.htm

2008-11-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-11-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018344.txt Sec File: edgar/data/901430/0001225208-08-018344-index.htm

2008-11-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-11-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018344.txt Sec File: edgar/data/901430/0001225208-08-018344-index.htm

2008-11-19 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 163600 shares at $6.735 remaining shares owned 36579454

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.00 to $6.60. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-11-21 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018344.txt Sec File: edgar/data/901430/0001225208-08-018344-index.htm

2008-11-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 258000 shares at $5.942 remaining shares owned 36321454

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f2 representatives of the reporting person have indicated that these sales were made to satisfy margin calls on loans. the shares were previously pledged to collateralize the loans.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $6.29 to $5.66. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-11-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018141.txt Sec File: edgar/data/901430/0001225208-08-018141-index.htm

2008-11-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 300000 shares at $7.259 remaining shares owned 36743054

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $7.42 to $7.10. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-11-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018141.txt Sec File: edgar/data/901430/0001225208-08-018141-index.htm

2008-11-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f3 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-11-19 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-018141.txt Sec File: edgar/data/901430/0001225208-08-018141-index.htm

2008-11-18 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f2 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016584.txt Sec File: edgar/data/901430/0001225208-08-016584-index.htm

2008-10-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 65800 shares at $8.91 remaining shares owned 37043054

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the transactions reported on this form 4 represent the automatic involuntary sale of boston scientific common stock. these shares were previously pledged to collateralize a loan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.90 to $8.98. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-10-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016584.txt Sec File: edgar/data/901430/0001225208-08-016584-index.htm

2008-10-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-23 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016584.txt Sec File: edgar/data/901430/0001225208-08-016584-index.htm

2008-10-21 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016498.txt Sec File: edgar/data/901430/0001225208-08-016498-index.htm

2008-10-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 634200 shares at $8.9 remaining shares owned 37108854

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the transactions reported on this form 4 represent the automatic involuntary sale of boston scientific common stock. these shares were previously pledged to collateralize a loan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.85 to $8.94. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-10-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016498.txt Sec File: edgar/data/901430/0001225208-08-016498-index.htm

2008-10-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f3 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-22 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016498.txt Sec File: edgar/data/901430/0001225208-08-016498-index.htm

2008-10-20 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f4 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016416.txt Sec File: edgar/data/901430/0001225208-08-016416-index.htm

2008-10-17 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 380967 shares at $8.6778 remaining shares owned 37743054

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the transactions reported on this form 4 represent the automatic involuntary sale of boston scientific common stock. these shares were previously pledged to collateralize a loan.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.60 to $8.78. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016416.txt Sec File: edgar/data/901430/0001225208-08-016416-index.htm

2008-10-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 619033 shares at $8.6097 remaining shares owned 38124021

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the transactions reported on this form 4 represent the automatic involuntary sale of boston scientific common stock. these shares were previously pledged to collateralize a loan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.30 to $8.70. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016416.txt Sec File: edgar/data/901430/0001225208-08-016416-index.htm

2008-10-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-20 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016416.txt Sec File: edgar/data/901430/0001225208-08-016416-index.htm

2008-10-16 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016307.txt Sec File: edgar/data/901430/0001225208-08-016307-index.htm

2008-10-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016307.txt Sec File: edgar/data/901430/0001225208-08-016307-index.htm

2008-10-15 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 194376 shares at $9.38 remaining shares owned 38743054

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the transactions reported on this form 4 represent the automatic involuntary sale of boston scientific common stock. these shares were previously pledged to collateralize a loan.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.16 to $9.60. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-10-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016307.txt Sec File: edgar/data/901430/0001225208-08-016307-index.htm

2008-10-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 805624 shares at $9.32 remaining shares owned 38937430

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the transactions reported on this form 4 represent the automatic involuntary sale of boston scientific common stock. these shares were previously pledged to collateralize a loan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.03 to $9.52. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-10-16 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016307.txt Sec File: edgar/data/901430/0001225208-08-016307-index.htm

2008-10-14 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 351098

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016088.txt Sec File: edgar/data/901430/0001225208-08-016088-index.htm

2008-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 1366259 shares at $9.411 remaining shares owned 52948365

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the transactions reported on this form 4 represent the automatic involuntary sale of boston scientific common stock. these shares were previously pledged to collateralize a loan.
f2 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $9.09 to $10.09. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-10-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016088.txt Sec File: edgar/data/901430/0001225208-08-016088-index.htm

2008-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 2093741 shares at $8.8533 remaining shares owned 50854624

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities

f1 the transactions reported on this form 4 represent the automatic involuntary sale of boston scientific common stock. these shares were previously pledged to collateralize a loan.
f3 the weighted average sales price is reported as stock sales were aggregated for reporting purposes. the per share transaction price ranged from $8.75 to $9.0850. the reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.


Filed on 2008-10-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016088.txt Sec File: edgar/data/901430/0001225208-08-016088-index.htm

2008-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f4 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-10-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-016088.txt Sec File: edgar/data/901430/0001225208-08-016088-index.htm

2008-10-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 361438

Common Stock Boston Scientific Corp Bsx

f5 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-008085.txt Sec File: edgar/data/901430/0001225208-08-008085-index.htm

2008-05-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 9104 shares at $0 remaining shares owned 54314624

Common Stock Boston Scientific Corp Bsx Transaction code: A Grant, award, or other acquisition

f1 annual grant of restricted stock vesting upon the expiration of non-employee director's current term of office. reflects a value of $125,000 divided by the closing price of common stock on the date of the grant.


Filed on 2008-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-008085.txt Sec File: edgar/data/901430/0001225208-08-008085-index.htm

2008-05-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f2 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2008-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-08-008085.txt Sec File: edgar/data/901430/0001225208-08-008085-index.htm

2008-05-06 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 361438

Common Stock Boston Scientific Corp Bsx

f3 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2007-05-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004605.txt Sec File: edgar/data/901430/0001225208-07-004605-index.htm

2007-05-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 400000

Common Stock Boston Scientific Corp Bsx

f2 common stock held by the reporting person's wife. the reporting person disclaims beneficial ownership of these shares.


Filed on 2007-05-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004605.txt Sec File: edgar/data/901430/0001225208-07-004605-index.htm

2007-05-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 7238 shares at $0 remaining shares owned 54305520

Common Stock Boston Scientific Corp Bsx Transaction code: A Grant, award, or other acquisition

f1 annual grant of restricted stock vesting upon the expiration of non-employee director's current term of office. reflects a value of $120,000 divided by the closing price of common stock on the date of the grant.


Filed on 2007-05-10 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004605.txt Sec File: edgar/data/901430/0001225208-07-004605-index.htm

2007-05-08 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp remaining shares owned 361438

Common Stock Boston Scientific Corp Bsx

f3 common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. the reporting person disclaims beneficial ownership of these shares.


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 1394 shares at $16.29 remaining shares owned 54442368

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 1269 shares at $16.31 remaining shares owned 54443762

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 1206 shares at $16.36 remaining shares owned 54445031

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 971 shares at $16.17 remaining shares owned 54446237

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 971 shares at $16.19 remaining shares owned 54447208

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 846 shares at $16.16 remaining shares owned 54448179

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 721 shares at $16.37 remaining shares owned 54449025

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 611 shares at $16.16 remaining shares owned 54449746

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 564 shares at $16.38 remaining shares owned 54450357

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 345 shares at $16.13 remaining shares owned 54450921

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 16 shares at $16.35 remaining shares owned 54451266

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004529.txt Sec File: edgar/data/901430/0001225208-07-004529-index.htm

2007-05-04 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp bought 181000 shares at $12.41 remaining shares owned 54451282

Common Stock Boston Scientific Corp Bsx Transaction code: M Exercise or conversion of derivative security

f1 exercise of option to purchase common stock prior to expiration on may 5, 2007.


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 200 shares at $16.63 remaining shares owned 54298282

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 200 shares at $16.57 remaining shares owned 54298482

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 200 shares at $16.63 remaining shares owned 54298682

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 200 shares at $16.62 remaining shares owned 54298882

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100 shares at $16.65 remaining shares owned 54299082

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100 shares at $16.53 remaining shares owned 54299182

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100 shares at $16.54 remaining shares owned 54299282

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100 shares at $16.64 remaining shares owned 54299382

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100 shares at $16.49 remaining shares owned 54299482

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100 shares at $16.5 remaining shares owned 54299582

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100 shares at $16.55 remaining shares owned 54299682

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100 shares at $16.46 remaining shares owned 54299782

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data/901430/0001225208-07-004527-index.htm

2007-05-07 Abele John E (CIK 901430) through Direct

Invested in Boston Scientific Corp sold 100 shares at $16.64 remaining shares owned 54299882

Common Stock Boston Scientific Corp Bsx Transaction code: S Open market or private sale of securities


Filed on 2007-05-08 by Abele John E SEC CIK 901430 Form 4

Accession 0001225208-07-004527.txt Sec File: edgar/data